Skip to main content
PLOS Pathogens logoLink to PLOS Pathogens
. 2021 Apr 30;17(4):e1009550. doi: 10.1371/journal.ppat.1009550

Salmonella enters a dormant state within human epithelial cells for persistent infection

Chak Hon Luk 1,2, Camila Valenzuela 1,#, Magdalena Gil 1,#, Léa Swistak 1,2,#, Perrine Bomme 3, Yuen-Yan Chang 1, Adeline Mallet 3, Jost Enninga 1,2,*
Editor: Jean Celli4
PMCID: PMC8115778  PMID: 33930101

Abstract

Salmonella Typhimurium (S. Typhimurium) is an enteric bacterium capable of invading a wide range of hosts, including rodents and humans. It targets different host cell types showing different intracellular lifestyles. S. Typhimurium colonizes different intracellular niches and is able to either actively divide at various rates or remain dormant to persist. A comprehensive tool to determine these distinct S. Typhimurium lifestyles remains lacking. Here we developed a novel fluorescent reporter, Salmonella INtracellular Analyzer (SINA), compatible for fluorescence microscopy and flow cytometry in single-bacterium level quantification. This identified a S. Typhimurium subpopulation in infected epithelial cells that exhibits a unique phenotype in comparison to the previously documented vacuolar or cytosolic S. Typhimurium. This subpopulation entered a dormant state in a vesicular compartment distinct from the conventional Salmonella-containing vacuoles (SCV) as well as the previously reported niche of dormant S. Typhimurium in macrophages. The dormant S. Typhimurium inside enterocytes were viable and expressed Salmonella Pathogenicity Island 2 (SPI-2) virulence factors at later time points. We found that the formation of these dormant S. Typhimurium is not triggered by the loss of SPI-2 effector secretion but it is regulated by (p)ppGpp-mediated stringent response through RelA and SpoT. We predict that intraepithelial dormant S. Typhimurium represents an important pathogen niche and provides an alternative strategy for S. Typhimurium pathogenicity and its persistence.

Author summary

Salmonella Typhimurium is a clinically relevant bacterial pathogen that causes Salmonellosis. It can actively or passively invade various host cell types and reside in a Salmonella-containing vacuole (SCV) within host cells. The SCV can be remodeled into a replicative niche with the aid of Salmonella Type III Secretion System 2 (T3SS2) effectors or else, the SCV is ruptured for the access of the nutrient-rich host cytosol. Depending on the infected host cell type, S. Typhimurium undertake different lifestyles that are distinct by their subcellular localization, replication rate and metabolic rate. We present here a novel fluorescent reporter system that rapidly detects S. Typhimurium lifestyles using fluorescence microscopy and flow cytometry. We identified a dormant S. Typhimurium population within enterocyte that displays capacities in host cell persistence, dormancy exit and antibiotic tolerance. We deciphered the (p)ppGpp stringent response pathway that suppresses S. Typhimurium dormancy in enterocytes while promoting dormancy in macrophages, pinpointing a divergent physiological consequence regulated by the same set of S. Typhimurium molecular mediators. Altogether, our work demonstrated the potential of fluorescent reporters in facile bacterial characterization, and revealed a dormant S. Typhimurium population in human enterocytes that are phenotypically distinct from that observed in macrophages and fibroblasts.

Introduction

Salmonella enterica serovar Typhimurium (S. Typhimurium) is an enteric bacterium that closely associates with global food-borne illnesses. The prevalence of S. Typhimurium has placed a severe burden on the global food and healthcare industry, leading to millions of cases, hundreds of casualties and costing billions of dollars per annum [1,2]. S. Typhimurium resides in different natural reservoirs and is transmitted to humans through contaminated food.

Upon arrival in the human intestine after ingestion, a portion of the luminal S. Typhimurium expresses the Type III Secretion System 1 (T3SS1) encoded within Salmonella Pathogenicity Island 1 (SPI-1) and its cognate effectors to induce its active entry into non-phagocytic epithelial cells. S. Typhimurium also targets other cell types, such as fibroblasts and macrophages. During these events, it induces local tissue injuries and eventually breaches the intestinal barrier to reach the lamina propria and tissue-resident immune cells. Then, S. Typhimurium is carried by macrophages to mesenteric lymph nodes and eventually to the liver and spleen for persistent infection [3].

Within enterocytes S. Typhimurium are encapsulated in an endocytic compartment coined Salmonella-containing vacuole (SCV) that matures by acidification within the first hours of internalization [4]. The reducing pH and changing osmolarity of the SCV induce the shutdown of T3SS1 and expression of a second T3SS, T3SS2, from Salmonella Pathogenicity Island 2 (SPI-2) [5,6]. The T3SS2 effectors remodel the SCV into a viable niche for S. Typhimurium replication [5,6]. Default maturation of the SCV is marked by the sequential acquisition and removal of endocytic trafficking markers, such as the small GTPases RAB5 and RAB7 as well as Lysosome-associated membrane glycoprotein 1 (LAMP1) [7]. During these events, the SCV dynamically interacts with surrounding macropinosomes, which controls SCV stability [8,9]. Consequently, S. Typhimurium can reside either in a remodeled SCV or disrupt the SCV to access the host cytosol. Overall, S. Typhimurium exhibits distinct replication rates and specific metabolic profiles within the different intracellular niches adapting to nutrient availability and the specific microenvironments [810].

Differential lifestyles are also known for S. Typhimurium infecting other cell types. In fibroblasts, the SCV associates with the aggrephagy machinery that either clears the infection or allows S. Typhimurium to putatively persist in the cell [11,12]. In macrophages, S. Typhimurium expresses the T3SS2 to remodel the SCV immediately after bacterial entry, or the pathogen adopts a dormant behavior mediated by toxin-antitoxin (TA) system [13,14].

Antibiotic persistence and relapse of S. Typhimurium infection due to the failure of bacterial eradication through antibiotic treatment has been tied to S. Typhimurium dormancy, which is distinct from bacterial persistence that refers to incompletely cleared infections by the immune system. Numerous antibiotics target major active machineries, including DNA replication, transcription and translation of extracellular bacteria, therefore dormant intracellular pathogens appear to be less or not susceptible to such treatments [15]. S. Typhimurium dormancy and antibiotics persistence have been reported in macrophages to be regulated by the Guanosine pentaphosphate (ppGpp) stringent response pathway. The two (p)ppGpp synthases RelA and SpoT control the bacterial (p)ppGpp level, which regulates the activity of the ATP-dependent protease Lon to degrade the antitoxin and release the toxin TacT for arresting protein translation [14,16]. The arrest of translation by TacT leads to a halt of bacterial growth giving rise to the insensitivity and tolerance towards antibiotics [16]. Despite reports of S. Typhimurium antibiotics persistence in the epithelium and lamina propria of the mouse intestine, it is not clear whether this involves dormant bacteria [17].

With our Salmonella INtracellular Analyzer (SINA) system, we precisely depicted the intracellular bacterial lifestyles at the single bacterium level, identifying a novel S. Typhimurium population within enterocytes that is dormant. Dormant persisters within enterocytes are localized in a unique vacuolar compartment different from the one described in macrophages. We found that T3SS2 effector secretion and the Lon protease are dispensable for this new S. Typhimurium population, while the bifunctional enzyme SpoT and monofunctional enzyme RelA negatively regulate S. Typhimurium dormancy in epithelial cells.

Results

Development of a multiplex fluorescent reporter series, the Salmonella INtracellular Analyser (SINA) to distinguish different intracellular S. Typhimurium lifestyles

The distinct intracellular lifestyles of S. Typhimurium upon invasion of epithelial cells have been described either with regard to the specific pathogen localization or with regard to the bacterial growth dynamics. To date, fluorescent reporters are available to identify S. Typhimurium within vacuolar and cytosolic localizations; while the others measure the replication rate of the pathogen [1820]. However, these localization and replication-rate reporters have not been coupled, as it has been generally assumed that the bacterial localization determines its replication rate. This notion has been challenged by different reports, for example on the different growth rates of S. Typhimurium within the cytosol depending on the targeting by autophagy [2125]. A combined reporter system would enable a comprehensive elucidation of the intracellular lifestyle of a given intracellular pathogen. Therefore, we developed a novel fluorescent reporter series, the Salmonella INtracellular Analyzer (SINA). Our SINA1.1 reporter is composed of two separated modules to indicate the bacterial localization and replication rate. The localization module consists of two transcription reporters driven by localization-specific promoters, while the replication rate module carries a constitutively expressed fluorescent timer (Figs 1A and S1). At the molecular level, the localization module is composed of vacuolar (Vac) and cytosolic (Cyt) submodules, which utilize two characterized promoters, PssaG and PuhpT to drive the expression of tagBFP and smURFP, respectively [18,19]. We confirmed the functionality of the fluorescent PssaG and PuhpT reporters for our experimental setup during S. Typhimurium invasion of epithelial cells using a digitonin assay assayed by flow cytometry (S2 and S3 Figs). The replication rate module encodes Timerbac, a DsRed mutant (S197T), which has been previously employed to differentiate S. Typhimurium subpopulations by their replication rates [20]. The emission spectrum of Timerbac shifts from green to red as it matures, which reflects the bacterial metabolic activity (change in slope, Fig 1B top) as well as the replication rate (unvarying slope, varying green:red ratio, Fig 1B bottom) [26]. When Timerbac is constitutively expressed, a metabolically active S. Typhimurium bacterium emits both green and red signals resulting from immature green and mature red fluorophores. In case such a bacterium experiences a metabolic halt, it eventually emits only red signals, due to the maturation of the existing green fluorophores in concert with ceased de novo synthesis of the green fluorophores. With SINA, we are able to simultaneously collect information on these replication rate changes of S. Typhimurium and its localization at single bacterium resolution, which enables a comprehensive and quantitative reflection of S. Typhimurium physiology inside an infected host.

Fig 1. SINA enables precise determination of the different Salmonella intracellular lifestyles in human epithelial cells.

Fig 1

(A) Schematic diagram of the construction of subcellular localization and replication rate modules of SINA1.1. The subcellular localization module is composed of the vacuolar submodule (PssaG-tagBFP) and cytosolic submodule (PuhpT-smURFP), while the replication rate module is composed of a constitutively expressed Timerbac (PybaJ-Timerbac) (B) (Top) Schematic diagram of the emission spectrum shifts of S. Typhimurium harboring Timerbac as Timerbac matures, where emission shifts from green to red (Bottom) Green:Red ratio increases with elevating S. Typhimurium replication rates. As S. Typhimurium divides, both Timer510 and Timer580 fluorophores are diluted. With a higher production rate of Timer510 than Timer580, fast dividing S. Typhimurium exhibits a higher Green:Red ratio. (C) Expected output by SINA as S. Typhimurium dwells in distinct subcellular localizations. Vacuolar S. Typhimurium are of lower replication rate (i.e. lower Green:Red ratio) and are expected to emit blue fluorescence; cytosolic S. Typhimurium are of higher replication rate (i.e. higher Green:Red ratio) and are expected to emit far red fluorescence (D) HeLa cells infected by S. Typhimurium harboring SINA1.1. Output of SINA from intracellular S. Typhimurium was detected by fluorescence microscopy at 1 h pi, vacuolar (arrowhead) and cytosolic (arrow) S. Typhimurium at 6 h pi. (3 independent experiments). Scale bars are 10 μm. (E) HeLa cells infected by S. Typhimurium harboring SINA1.1. Output of SINA from intracellular S. Typhimurium at 1 h and 6 h pi was detected by flow cytometry (3 independent experiments).

To validate the functionality of our SINA system during S. Typhimurium invasion of epithelial cells, we employed fluorescence microscopy and flow cytometry analysis (Fig 1C). With fluorescence microscopy, we observed intracellular S. Typhimurium simultaneously emitting both green and red signals (Timerbac), but not Vac (PssaG-tagBFP) and Cyt (PuhpT-smURFP) signals at 1 hour post-infection (pi) (Fig 1D). As these bacteria committed to vacuolar or cytosolic lifestyles at 6 hours pi, we observed that S. Typhimurium in cells with <10 bacteria emitted Vac signal during this time course. On the other hand, we observed a mixed population of S. Typhimurium in cells with >10 bacteria, where clusters of Cyt+ S. Typhimurium of low Timerbac signals (arrow) and individual Vac+ S. Typhimurium (arrowhead) were detected. In the cells containing mixed S. Typhimurium populations, bacteria were either Vac+ or Cyt+ but not double positive, showing the presence of two populations with distinct discernible lifestyles (Fig 1D). We were also able to track the onset of bacterial division and signal output from SINA by time-lapse microscopy (S1S3 Movies, S4B and S4C Fig).

We took advantage of the properties of our multiplex SINA reporter and devised a gating strategy to quantitatively analyze the bacterial lifestyles in single S. Typhimurium-infected cells using flow cytometry (S2 Fig). In brief, we first defined the infected cells by the size of the analyzed events (under SSC-A vs FSC-A plot), followed by the positive signals in the Timer580 vs Timer510 plot (i.e. cells harboring S. Typhimurium). We then further classified the S. Typhimurium-infected cells into four sub-types according the signals of the localization module (tagBFP::SPI-2 vs smURFP::cytosolic plot), corresponding to cells with either vacuolar bacteria (Vac+Cyt-) or cytosolic bacteria (Vac-Cyt+) or cells with both vacuolar and cytosolic populations (Vac+Cyt+) or cells harboring S. Typhimurium that express only basal levels of the Vac and Cyt signals (S2 Fig). We observed that intracellular S. Typhimurium behaved as a population with a homogenous replication rate and basal expression levels of Vac and Cyt at 1 hour pi (Fig 1E). At 6 hours pi, this homogenous population segregated into Vac+ and Cyt+ subpopulations, with a Cyt+ distribution similar to that reported in the literature (10–20% cytosolic) (Fig 1E) [21]. The gradual separation of these subpopulations could be detected with SINA1.1 throughout the course of infection (S4A Fig). As we backgated the infected cells, we observed cells harboring only vacuolar S. Typhimurium (Vac+Cyt-) and cells with both vacuolar and cytosolic bacteria (Vac+Cyt+), each forming a distinct population of different Green:Red ratio on the plot of Timer510 against Timer580 (S5A Fig). Together, this demonstrated that our novel SINA1.1 reporter is capable of simultaneously and quantitatively distinguishing the S. Typhimurium lifestyles by their subcellular localization and replication rate at both single infected cell and single bacterium level using flow cytometry and fluorescence microscopy. The combination of the SINA reporter with flow cytometry fosters higher throughput analysis of S. Typhimurium lifestyles in infected cells as compared to microscopy, extending the possibility for rapid screening.

A novel dormant S. Typhimurium subpopulation in human epithelial cell

With the SINA1.1 reporter, we used the SPI-2 expression module to distinguish vacuolar S. Typhimurium from cytosolic bacteria. In the plot of the localization module, we identified an easily discernable population (~5–10%) of infected epithelial cells harboring Vac-Cyt- S. Typhimurium detectable as early as 2 hours pi, which became apparent at 6 hours pi (Figs 2A and S6). We backgated the Vac-Cyt- population, and we extracted physical parameters from the Timerbac plot. This revealed that the Vac-Cyt- S. Typhimurium exhibit a similar replication rate (S5A Fig) but a reduced metabolic activity (S5B Fig) compared to Vac+Cyt- S. Typhimurium as depicted by the green:red ratio and slope of Timerbac plot, respectively. The capacities of Timerbac in the measurement of the bacterial replication rate and metabolism have been well-elaborated in previous applications [20,27]. This Vac-Cyt- S. Typhimurium population was also visualized using live microscopy to confirm their presence using different detection approaches (S3 Movie). This was intriguing as metabolically inactive S. Typhimurium have not been reported in enterocytes so far. We thus infected polarized intestinal epithelial Caco-2 monolayers, and confirmed the presence of the Vac-Cyt- subpopulation with a shifted metabolic profile in a cellular model system for intestinal infections (S7 Fig). We also performed control infections in 3T3 (fibroblast model) and differentiated THP-1 cells (macrophage model) to test the sensitivity of SINA1.1 in these relevant cell types. As within epithelial cells, we also observed distinct S. Typhimurium populations in the macrophage and fibroblast models as described before (S8 and S9 Figs). To determine the intracellular localization of Vac-Cyt- S. Typhimurium, we further performed correlative light and electron microscopy (CLEM) by serial section transmission electron microscopy (TEM), and a digitonin assay demonstrating that this subpopulation is localized in a host vesicular compartment (Figs 2B, S4A–S4F and S10) [21]. Together, these results showed the presence of a novel intracellular S. Typhimurium population within epithelial cells that exhibits a lowered metabolic rate and resides in a host vesicular compartment, implicating a putative dormant phenotypic variant.

Fig 2. S. Typhimurium displays a novel inactive intracellular lifestyle in epithelial cells.

Fig 2

(A) (Left and Middle) Timerbac profile and distribution of single cells with no infection (black), infected cells with inactive bacteria (Vac-Cyt-) (red), infected cells with only vacuolar bacteria (Vac+Cyt-) (blue) and infected cells with both vacuolar and cytosolic populations (Vac+Cyt+) (green) at 6 h pi. (Right) Abundance of S. Typhimurium-infected cells (Vac-Cyt-, Vac+Cyt- and Vac+Cyt+) as illustrated in (A) (n = 3). (B) (Left) Brightfield and fluorescent microcopy (FLM) images of infected HeLa cells harboring Vac-Cyt- S. Typhimurium at 6 h pi. (Right) Serial sections of TEM images of Vac-Cyt- S. Typhimurium, arrowhead indicates host membrane structures of the SCV. (C) Schematic illustration for the constructions of SINA derivatives, SINA1.4 and SINA1.5. SINA1.4 was used for immunofluorescence staining against RAB5, RAB7, RAB11, LAMP1 and LC3; SINA1.5 was used for arabinose induction assay. (D) (Top) Responsiveness of intracellular S. Typhimurium towards an arabinose pulse between 5–6 h pi, uninduced control (black); arabinose-induced (red). (Bottom) Quantification on the responsiveness of Vac- S. Typhimurium pulsed at different time intervals during the infection time course, dormant (black), inducible (maroon). Samples were all harvested at 6 h pi. (n = 3) (E) HeLa cells were infected with SINA1.4-harboring S. Typhimurium, harvested at 6 h pi, fixed and stained. Quantification of the presence of RAB5, RAB7, BAB11, LAMP1 and LC3 proximal to Vac- and Vac+ S. Typhimurium at 6 h pi. (n = 3) (F) Representative images of Vac- S. Typhimurium (arrow) quantified in (D); S. Typhimurium (green), Vac- (blue), RAB5, RAB7, RAB11, LAMP1 and LC3 (grey), Phalloidin (red). (G) Designated populations of infected HeLa cells were enriched by cell sorting and plated for CFU. Quantification of CFU from dormant S. Typhimurium at 6 h, 24 h and 168 h pi and Vac+Cyt- S. Typhimurium at 6 h pi. (n = 5 for Vac+Cyt- 6 h, Dormant 6 h, 24 h; n = 3 for Dormant 168 h) (H) Quantification of SPI-2 activity using flow cytometry in enriched dormant S. Typhimurium at 6 h and enriched Vac-Cyt- infected cells re-plated until 24 h pi. (n = 3) (I) Survival percentage of dormant and Vac+Cyt- intracellular S. Typhimurium against 3 h of CIP treatment, infected cells were harvested at 6 h pi, enriched by cell sorting and plated for CFU. (n = 4) At least a total of 1000 events of infected cells were analyzed by flow cytometry or 50 infected cells by microscopy in each experiment replicates. The bars represent the mean, statistics were performed using unpaired t test (**p<0.01).

Intracellular S. Typhimurium encounters a number of stresses upon uptake into host cells, including oxidative, pH and osmotic stress, which serve as key signals to trigger transcription reprogramming for the adaptation of an intra-host environment [28]. As the intracellular microenvironment and S. Typhimurium dormancy has been studied in some detail in macrophages, we decided to focus our comparison on this cell type in relation to the newly identified S. Typhimurium subpopulation in epithelial cells. During macrophage infections the SCV microenvironment drives a portion of S. Typhimurium into a dormant state that contributes to the elevation of antimicrobial persistence and polarization of infected macrophage [14,29]. We asked whether Vac-Cyt- S. Typhimurium shares similar physiologies with dormant S. Typhimurium inside macrophages, hence we determined the metabolic state of the Vac-Cyt- population. By replacing the cytosolic submodule of SINA1.1 with an arabinose inducible cassette to generate SINA1.5, we measured S. Typhimurium’s capacity to respond to arabinose treatment. This modification enabled us to directly monitor the metabolic activity of S. Typhimurium during the infection process (Fig 2C). The response of intracellular bacteria towards extracellular arabinose induction has been reported previously to characterize the metabolic state of macrophage-borne dormant S. Typhimurium [13]. With SINA1.5, we observed that approximately half of the Vac- S. Typhimurium did not respond to arabinose induction at designated time intervals (Fig 2D). As the Vac-Cyt- bacterial niche may show limited arabinose accessibility, we corroborated our observations monitoring the reduced metabolism of this bacterial population via the signals of the Timerbac reporter (S5B Fig). These data allowed us to propose that the Vac-Cyt- S. Typhimurium adopts a dormant state (coined as dormant S. Typhimurium hereafter) upon their internalization into epithelial cells.

Dormant S. Typhimurium resides in a unique vesicular compartment

We set out to determine whether the dormant S. Typhimurium localization is distinct from conventional SCVs. To determine this by immunofluorescence staining, we simplified SINA1.1 to SINA1.4 to free the red and far-red channels for indirect immunofluorescence staining of selected endocytic markers (Fig 2C). LAMP1 labels host lysosomes as well as the matured SCV, which is also present on the SCV of dormant S. Typhimurium in macrophages [7,13]. By fluorescence microscopy, we only observed minor recruitment of LAMP1 to the proximity of dormant S. Typhimurium within epithelial cells, in contrast to the high LAMP1 incidence proximal to Vac+ S. Typhimurium (Fig 2E and 2F). We also determined if dormant S. Typhimurium is localized in a SCV experiencing a halt in SCV biogenesis, therefore we tested a number of known early SCV markers (namely RAB5, RAB7 and RAB11). We did not observe the recruitment of any of these early SCV markers to the dormant S. Typhimurium (Fig 2E and 2F). This was intriguing as our previous ultrastructural and digitonin investigations clearly documented the dormant S. Typhimurium bacteria within a membrane-bound compartment. We also addressed if the dormant population is targeted by host autophagy, analyzing the localization of the autophagy marker LC3. We did not detect any localization of LC3 proximal to the majority of the dormant S. Typhimurium (Fig 2E and 2F). Therefore, we conclude that dormant S. Typhimurium are localized within a unique membrane-bound compartment distinct from the conventional SCV and that of dormant S. Typhimurium in macrophages, suggesting such dormancy formation is heavily governed by endocytic trafficking [13,30]. This compartment requires further characterization in future studies.

Dormant S. Typhimurium are viable, cultivable, resume metabolism and express virulence genes in host cells

Endocytic vesicles are either recycled or undergo fusion with the lysosomes for degradation. The same fate also applies to vacuolar S. Typhimurium, where SPI-2 deficient strains have a reduced survival capacity compared to SPI-2 competent strains [31]. We collected the infected cells harboring dormant S. Typhimurium by cell sorting at >90% purity and plated them for colony forming unit (CFU) measurement, a classical approach to determine the viability of the intracellular S. Typhimurium. We observed that dormant S. Typhimurium are viable and cultivable (Fig 2G), contrasting to the viable but not cultivable nature of dormant S. Typhimurium in murine macrophages [13,14]. To determine the fate of the dormant S. Typhimurium, we enriched and plated the viable infected cells harboring dormant S. Typhimurium, and monitored the bacterial behavior at 24 hours pi (S11 Fig). We observed that 50% of the dormant S. Typhimurium in infected cells collected at 6 hours pi became metabolically active and expressed SPI-2 at 24 hours pi, as demonstrated by the population shift in the Timerbac plot, and becoming Vac+ (Fig 2H). To determine if the dormant S. Typhimurium persists in the host, we further enriched infected cells harboring dormant S. Typhimurium and monitored the presence and the viability of dormant S. Typhimurium at 7 days pi. The dormant S. Typhimurium were found to persist in cells and remained viable and cultivable over the whole period of 7 days (Fig 2G, “168h”). To further address whether the dormant intracellular S. Typhimurium phenotype confers a reduced sensitivity towards antibiotics, we supplemented ciprofloxacin (CIP) to the infected cell at 3 hours pi and determined the viability of dormant S. Typhimurium by CFU. We selected the in cellulo CIP supplementation to avoid artificial perturbations on the S. Typhimurium dormant status. Also, in cellulo treatment addresses the killing efficiency of dormant S. Typhimurium within the SCV, where subcellular distribution of this drug has been demonstrated to influence the bactericidal efficacy [32]. We observed a higher survival rate of dormant S. Typhimurium as compared to vacuolar S. Typhimurium (Fig 2I), similar to the observations made in the murine intestine [17]. These results demonstrated that dormant S. Typhimurium are viable, exhibit a delayed expression of SPI-2, persist in the epithelial host cells for up to 7 days and are less susceptible to antibiotics. Such unique metabolic and virulence reprogramming could serve as a strategic step for intestine-borne S. Typhimurium to prolong gut inflammation for community benefits and reservoir for relapse [33].

S. Typhimurium dormancy is not a result of the loss of T3SS2 effector secretion

We then studied whether the lack of T3SS2 effector secretion drives S. Typhimurium dormancy in epithelial cells. Using our SINA1.1 reporter in the S. Typhimurium SPI-2 secretion deficient mutant ΔssaV [34], we observed no significant difference in the proportion of Vac-Cyt- S. Typhimurium between wild type and the ΔssaV mutant (Fig 3A). Altogether, the formation of dormant S. Typhimurium is not a consequence caused by the lack of T3SS2 effector secretion during the infection of epithelial cells.

Fig 3. S. Typhimurium dormancy is negatively regulated by SpoT.

Fig 3

(A) HeLa cells were infected with SINA1.1-harboring S. Typhimurium, the abundance of Vac-Cyt- population in wild type and SPI-2 mutant ΔssaV infected cells were quantified with flow cytometry at 6 h pi. (n = 3) (B) Schematic diagram for the construction of SINA derivative, SINA1.9, yielded from the introduction of an arabinose-inducible hilA expression cassette into SINA1.1. SINA1.9 was used to rescue the reduced invasiveness of ΔdksA, ΔrelA and ΔrelAspoT mutant strains. (C) HeLa cells were infected with SINA1.1 or SINA1.9-harboring S. Typhimurium, the abundance of Vac-Cyt- population in (p)ppGpp biogenesis and regulon mutants, Δlon, ΔdksA, ΔrelA and ΔrelAspoT were quantified by flow cytometry at 6 h pi (n = 3) (D) Distribution of Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ populations in hilA-expressing wild type (Left) and ΔrelAspoT mutant (Middle) infected HeLa cells at 6 h pi quantified by flow cytometry. Overlay Timerbac profile (Right) of Vac-Cyt- (red) and Vac+Cyt- (blue) populations of wild type and Vac-Cyt- population of ΔrelAspoT mutant (grey) in infected HeLa cells quantified by flow cytometry at 6 h pi. (3 independent experiments) At least a total of 1000 events of infected cells were analyzed by flow cytometry in triplicate experiments. Statistics were performed using unpaired t test. ns: not significant (P > 0.05), **P < 0.01, ****P < 0.0001.

S. Typhimurium dormancy is regulated by (p)ppGpp biogenesis

Class II toxin-antitoxin (TA) systems regulate the dormancy formation of non-pathogenic E. coli in laboratory conditions [35]. TA systems are comprised of a toxin and an antitoxin that counter-balances the toxin to regulate bacterial physiology, including growth arrest. A major TA system involves the stringent response mediated by the monofunctional (p)ppGpp synthases RelA and bifunctional (p)ppGpp synthases SpoT, after which (p)ppGpp binds to DksA to mediate transcription reprogramming for bacterial adaptation. The surge in (p)ppGpp levels also activates the ATP-dependent Lon protease to degrade Type II antitoxins to release the free toxins [3638]. In recent reports, stringent response has been associated with slow growing S. Typhimurium populations, and TA systems are implicated in S. Typhimurium dormancy in macrophages [14,16]. Therefore, we assessed the links between the stringent response and S. Typhimurium dormancy in epithelial cells, studying the mutant strains (i) ΔrelA ((p)ppGpp synthase), (ii) ΔrelAΔspoT ((p)ppGpp synthases), (iii) ΔdksA ((p)ppGpp-binding transcription regulator) and (iv) Δlon (protease targeting antitoxin). With the Δlon mutant, we did not observe any difference in the level of dormant S. Typhimurium population in infected cells (~5–10%), suggesting that Lon protease is dispensable for S. Typhimurium dormancy in epithelial cells (Fig 3C). As ΔrelAspoT and ΔdksA were reported to suffer reduced invasiveness in epithelial cells due to the reduced SPI-1 expression, we thus constructed SINA1.9 (Fig 3B), a derivative of SINA1.1 with an additional cassette for an inducible expression of hilA to compensate the reduced invasiveness of the mutants (S12 Fig) following a previously published experimental strategy [39]. With the SINA1.9-complemented mutant strains, we obtained rescued invasiveness as compared to wild type S. Typhimurium. This allowed us to address the requirement of (p)ppGpp biogenesis and (p)ppGpp-regulated transcription for S. Typhimurium persistence. A significant increase in the Vac-Cyt- population was observed in ΔrelAspoT, whereas the increment was less pronounced in the ΔrelA single mutant and was indifferent in ΔdksA mutant, when comparing with the wild type strain (Fig 3C and 3D, Left and Middle panel). As SpoT has been reported to regulate SPI-2 expression [40], we further confirmed that the Vac-Cyt- population of ΔrelAspoT shared a comparable metabolic profile as the one observed in the wild type strain (Fig 3D, Right panel). Together, these results suggested that (p)ppGpp stringent response mediated by SpoT but not RelA is required to restrict dormancy entry of S. Typhimurium within epithelial cells independent of the DksA regulon, while SPI-2 effector expression and secretion and Lon protease are dispensable.

Discussion

S. Typhimurium has been reported to survive in different host cells by adopting distinctive metabolic profiles, subcellular localizations and replication rates, which has also been proposed to account for various clinical complications. Herein, we report a dormant population of S. Typhimurium residing in a unique vesicular compartment in epithelial cells of the intestine. These dormant epithelial S. Typhimurium persist within host cells for a prolonged period. The SINA reporter system was instrumental for the discovery of enterocyte-borne dormant S. Typhimurium as it allowed the simultaneous depiction of the metabolism, subcellular localization and replication rate of the intracellular bacteria. The compatibility of the SINA system with microscopy and flow cytometry offers the opportunity for multi-omics analysis as well as high-throughput genetic and chemical screenings on genes and compounds that influence the bacterial pathophysiology.

The dormant S. Typhimurium, while remaining viable in the absence of SPI-2 expression, reside in a unique vesicular compartment distinct from the RAB5, RAB7, RAB11 or LAMP1-labelled SCV or the LC3-positive autophagosomes. Upon endocytosis, endosomes are either recycled or matured and eventually degraded via fusion with lysosomes. The SCV shares such a fate if T3SS2 effectors are not secreted to hijack the vesicular maturation pathway [34]. Therefore, we propose that dormant S. Typhimurium reside in a vesicular compartment idle to endocytic trafficking pathways that are independent of T3SS2 effectors. Such a diversion from default endocytic pathways is also observed by other bacterial pathogens, such as Shigella, and despite decades of research, no strong molecular markers have been identified for the short-lived Shigella containing vacuole [41]. The subsequent resumption of metabolism and SPI-2 expression potentially serve as a signal to reengage the dormant membrane-enclosed S. Typhimurium with endocytic trafficking pathways for remodeling the SCV into the conventional replicative niche (Fig 4A). The persistence of dormant S. Typhimurium in host cell for up to at least 7 days in our tested condition is also striking as the bacteria inside this vacuolar compartment are likely to have restricted access to the extracellular nutrients.

Fig 4. Schematic illustration of the role of (p)ppGpp alarmone pathway on S. Typhimurium dormancy in enterocytes and the proposed pathophysiological implication of S. Typhimurium dormancy in enterocytes.

Fig 4

(A) Schematic diagram of S. Typhimurium lifestyles and the regulatory role of SpoT on S. Typhimurium dormancy in human epithelial cells. S. Typhimurium can opt for three distinct lifestyles: cytosolic, vacuolar and dormant, which exhibits discernible subcellular localization, replication rate and metabolism. The entry of dormant state is negatively regulated by (p)ppGpp synthatase SpoT, while the regulatory mechanism on the dormancy exit remains to be determined. (B) Schematic diagram of S. Typhimurium infection progression in the gut epithelium. As S. Typhimurium reaches the intestinal epithelium, a portion of S. Typhimurium expresses T3SS1 (purple) to enter host cells and adopts various intracellular lifestyles. Distinct S. Typhimurium lifestyles support rapid tissue colonization and gut inflammation to increase competitiveness of luminal S. Typhimurium (red). (Top) Reactivation of dormant S. Typhimurium leads to prolonged gut inflammation that supports the continuous growth of S. Typhimurium at gut lumen. (Bottom) Dormant S. Typhimurium reactivates after the eradication of gut S. Typhimurium, which serves as the reservoirs of infection relapse.

S. Typhimurium has been reported previously to enter dormant or persistent states within a modified SCV from a range of host cell types, including macrophages and fibroblasts [12,13]. Considering the presumably identical S. Typhimurium dormancy observed across the different cell models, there are substantial distinctions among the targeted host cell types in terms of the detection approaches and bacterial physiology. The first S. Typhimurium antibiotics-tolerant persisters were identified in macrophages using a dilution reporter on non-replicating S. Typhimurium, which enters dormancy and a viable-but-not-cultivable state upon entry [13]. The dormancy is regulated by the TA system toxin, TacT that halts protein translation and induces antibiotic persistence, where the S. Typhimurium subsequently exits dormancy and activates SPI-2 [16,29]. Slow growing S. Typhimurium were also identified in fibroblasts as early as 2003, where 0.001% of the bacteria survived until the end of the studied time course [12]. Studies in fibroblasts have deciphered major genetic determinants of bacterial persistence, however the underlying mechanisms of persistence with regards to bacterial viability, antibiotics, the pathological implication have been characterized in more depth in macrophages recently [11,42]. In the different infected host cells intracellular S. Typhimurium activates SPI-2 to remodel the SCV for replication and interacts with endocytic trafficking pathways. In fibroblasts, the SCV subsequently interacts with host aggrephagy, where the majority of the S. Typhimurium residing in the SCV are eradicated whereas the remaining S. Typhimurium were proposed to persist [11]. In epithelial cells, the reported S. Typhimurium dormancy by us is distinct from that in fibroblast and macrophage. They are different in the commence of dormancy, the capacity to replicate and the SCV microenvironment [13]. The distinct niches of dormant S. Typhimurium may reflect cell-type specific vesicular trafficking, for example SPI-2 expression level and SCV maturation in these different target cells is not identical (S4, S8 and S9 Figs). It could also be possible that the way of entry impacts the development of dormant S. Typhimurium. Epithelial dormant S. Typhimurium is independent of Lon protease and is negatively regulated by SpoT, contrasting to that in macrophage that requires Lon protease, (p)ppGpp synthases RelA and SpoT [14,38]. The substantial difference between the S. Typhimurium dormancy sheds light on their potentially diverge pathophysiological implications as well as the molecular cue and mechanism that signal the establishment and exit of dormancy. The extensive work on TA systems and S. Typhimurium physiology in fibroblasts would serve as significant groundwork for the further studies of enterocyte-borne dormant S. Typhimurium [42]. It will be interesting to investigate why these regulatory modules are differentially involved in the formation of dormant S. Typhimurium in the different cell types, and whether the distinct niche impacts their expression and implication.

(p)ppGpp, is a bacterial alarmone that functions as a key regulator of bacterial physiology. The (p)ppGpp-mediated stringent response has been closely associated with antibiotics persistence via inhibition of protein synthesis and transcription reprogramming [4345]. The persistent S. Typhimurium in macrophages is dependent on a (p)ppGpp-Lon protease-Class II TA systems axis, where TacT leads to a halt in protein translation [16]. In non-pathogenic E. coli and S. Typhimurium models, the loss of Lon and its downstream regulated TA systems leads to a diminished antibiotics persister formation due to the inactivity of toxins [46]. In our findings, the dormant phenotype is negatively regulated by (p)ppGpp synthases SpoT and partially by RelA, but independent of DksA and Lon protease-mediated pathways (Fig 4A). Our finding contrasts the current understanding on the role of stringent response on bacterial persistence, where stringent response is activated by various stress signals and (p)ppGpp synthesis would act on its molecular target to achieve persistence. Therefore, we suggest that bifunctional SpoT is required while monofunctional RelA is dispensable in S. Typhimurium dormancy in enterocytes, which echoes the previous report on the requirement of SpoT but not RelA in S. Typhimurium invasion and colonization of an in vivo model [39]. The essence of SpoT but not RelA for S. Typhimurium dormancy could suggest that either or both the (p)ppGpp hydrolysis and synthase function is required, or relA is not expressed during the course of infection. Considering that S. Typhimurium dormancy is independent of DksA and Lon, it implies that dormancy is likely to be mediated by pathways independent of DksA transcription reprogramming and Lon protease-mediated degradation. As RelA and SpoT function to convert GDP and GTP to (p)ppGpp, and SpoT hydrolyzes (p)ppGpp to give GTP/GDP and pyrophosphate, an imbalance of RelA/SpoT activity upsets the bacterial energy status, which could potentially act as a cue for dormancy. As dormant S. Typhimurium do not co-exist with S. Typhimurium of other lifestyles (Fig 2F), the host cell status is also implied to serve a regulatory role on S. Typhimurium dormancy.

With the traits we uncovered in the dormant S. Typhimurium within epithelial cells, this population could represent the intestinal persister, given the close association between bacterial dormancy and antibiotic persistence. Besides the proposed antibiotic persistence and horizontal gene transfer, the physiological features of enterocyte-borne dormant S. Typhimurium could also provide two plausible benefits to S. Typhimurium colonization of the host gut [47] (Fig 4B): 1) Dormancy and delayed expression of SPI-2 allow S. Typhimurium to evade cellular immunity during early invasion and to provide a sustained and extended SPI-2 expression at tissue scale, where S. Typhimurium reactivated from dormancy supports SPI-2 expression as classic vacuolar S. Typhimurium is eradicated. The sustained SPI-2 expression fuels gut inflammation to release electron acceptors for S. Typhimurium survival benefits in the gut lumen [33]. 2) Persistent S. Typhimurium resided within the intestinal tissue serves as the source of subsequent infection relapse or systemic spread, where the maximum duration of persistence and molecular cues for reactivation remain to be elucidated (Fig 4B).

Materials and methods

Mammalian cell culture

HeLa cervical adenocarcinoma cells, Caco-2 colorectal adenocarcinoma cells, 3T3 mouse fibroblasts and THP-1 acute monocytic leukemia cells were purchased from American Type Culture Collection (ATCC) and used within 20 passages of receipt. HeLa cells and 3T3 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM, high glucose, GlutaMAX Supplement, ThermoFisher) containing 10% (v/v) heat-inactivated fetal bovine serum (FBS, Sigma) and incubated at 37°C with 5% CO2 and 100% humidity. Caco-2 cells were cultured in DMEM containing 10% FBS, 1% Non-essential amino acids (Gibco), 1% HEPES (Gibco), 1% Penicillin/Streptomycin (Gibco) and incubated at 37°C with 5% CO2 and 100% humidity. THP-1 cells were cultured in RPMI-1640 medium (ThermoFisher) containing 10% FBS and incubated at 37°C with 5% CO2 and 100% humidity. HeLa and 3T3 cells were seeded in 12-well tissue-culture treated plates (Corning Costar) at a density of 9x104 cells/well 48 hours prior to infection. Caco-2 cells were polarized using Corning BioCoat Assay System (Corning) following manufacturer’s protocol. THP-1 cells were seeded in 12-well tissue-culture treated plates at a density of 9x104 cells/well 96 hours prior to infection, and differentiated in 50 μg/mL phorbol 12-myristate 13-acetate (PMA, Sigma) for 24 hours, and incubated in RPMI-1640 + 10% for 72 hours. For immunofluorescence staining, HeLa cells were seeded on UV-treated glass coverslips (Marienfeld) in 12-well plates 48 hours prior to infection. For cell sorting experiments, HeLa cells were seeded in 10 cm tissue-culture treated dishes (Corning Costar) at a density of 1.8x106 cells/well 48 hours prior to infection.

Bacterial strains

Bacterial strains and plasmids used in this study are listed in S1 and S2 Tables, respectively. All mutants were constructed using bacteriophage λ red recombinase system from parental stain S. Typhimurium Typhimurium strain SL1344 using primers listed in S3 Table [48]. HA-tagged T3SS2 effector strains were generated by transducing JL129 with P22 phage lysate (a generous gift from Stéphane Méresse, Centre d’Immunologie de Marseille-Luminy, France). Bacteria were cultured in Lysogeny broth (LB) supplemented with appropriate antibiotics, where necessary (Ampicillin 100 μg/mL; Kanamycin 50 μg/mL).

Plasmid construction

The replication rate module, Timerbac is a generous gift from Dr. Dirk Bumann (University of Basel, Switzerland) [20]. To construct the localization module, tagBFP was amplified from pHRdSV40-NLS-dCas9-24xGCN4_v4-NLS-P2A-BFP-dWPRE using primers tagBFP_fw and tagBFP_rv, and replaced the GFP in pM973 to yield vacuolar module (pPssaG-tagBFP) [19,49]. For the cytosolic module (pPuhpT-smURFP), smURFP-HO-1 and uhpT promoters were amplified from pBAD smURFP-HO-1 (smURFP_fw and smURFP_rv) and S. Typhimurium gDNA (uhpT_fw and uhpT_rv), respectively, and replaced the sfGFP and mxiE promoter in pTSAR1 [50,51]. The vacuolar (Vac_fw and tagBFP_rv) and cytosolic (uhpT_fw and Cyt_rv) modules were amplified and inserted into EcoRV and SmaI sites, respectively, of pBlueScript II KS (+) to generate pSINA-int. The localization module on pSINA-int was excised and inserted between SalI and SphI sites of pBR322 Timerbac to yield pSINA1.1. pSINA1.4 was generated by replacing Timerbac with GFP in pBR322 Timerbac and inserted the vacuolar module at the SalI and SphI sites. pSINA1.5 was generated by inserting the amplified inducible smURFP cassette (Ara_fw and Ara_rv) and vacuolar cassette between the SalI and EagI sites of pBR322 Timerbac. pSINA1.7 was constructed by reverting Timerbac to DsRed by site-directed mutagenesis using DsRed_fw and DsRed_rv. pBAD hilA was generated by inserting the amplified hilA (hilA_fw1 and hilA_rv1) between the BamHI and PmeI sites of pBAD smURFP-HO-1. The inducible hilA cassette was amplified using primer hilA_fw2 and hilA_rv2 and inserted into the EcoRV site of pSINA1.1 to generate pSINA1.9.

Bacterial infections

Bacteria strains were streaked from glycerol stock on LB agar plates with appropriate antibiotics 2 days prior to infection. Three bacterial colonies were picked for overnight culture in LB medium supplemented with 0.3 M NaCl with shaking at 37°C. 150 μL overnight culture was subculture in 3 mL LB + 0.3 M NaCl (1:20 dilution) with shaking at 37°C for 3 h. For strains harboring pSINA1.9, 0.1% L-arabinose was supplemented to the subculture 1 h before harvest. Bacteria were harvested with centrifugation (1 mL, 6000 x g, 1 min, RT), washed once in 1 x PBS and resuspended in DMEM with no FBS. HeLa cells were infected at a MOI of ~100 for 25 min at 37°C. Extracellular bacteria were removed and washed with 1 x PBS (5X). Cells were then incubated in DMEM + 10% FBS for 1 h, washed with 1 x PBS (3X), incubated in DMEM + 10% FBS for 2 h, washed with 1 x PBS (3X) and then incubated in DMEM + 10% FBS supplemented with 10 μg/mL gentamicin for the remaining time course of the infection.

Flow cytometry

At designated time points, cells were washed with 1 x PBS (1X) and detached with 0.05% Trypsin for 5 min at 37°C. Detached cells were mixed with equal volume of DMEM + 10% FBS, passed through 40 μm strainer and collected by centrifugation (500 x g, 5 min, 4°C). Cell pellets were dislodged and fixed in 4% PFA (15 min, RT). Fixed cells were washed with 1 x PBS (2X) and resuspended in 200 μL 1 x PBS for further analysis. For digitonin permeabilization experiment, cells were permeabilized with 45 μg/mL digitonin (1 min, RT) or 0.25% saponin (30 min, RT), then washed and stained with anti-S. Typhimurium primary antibody and Alexa488-conjugated goat anti-rabbit secondary antibody [21]. The fluorescence intensities of the samples were assayed with LSR Fortessa (BD) (tagBFP Ex: 405 nm Em: 450/50 nm; Timer510 Ex: 488 nm Em: 525/50 nm; Timer580 Ex: 562 nm Em: 582/15 nm; smURFP Ex: 633 nm Em: 670/30 nm) and analyzed with FlowJo (v10.0.4). The recorded events were gated according to the strategy described (S2 Fig).

Cell sorting

At designated time points, cells were washed with 1 x PBS (1X) and detached with 0.05% Trypsin for 5 min at 37°C. Detached cells were mixed with equal volume of DMEM + 10% FBS, passed through 40 μm strainer and collected by centrifugation (500 x g, 5 min, 4°C). Cells were washed with 1 x PBS (1X) and resuspended in DMEM + 10% FBS supplemented with 10 μg/mL gentamicin. SYTOX Green (ThermoFisher) was supplemented to differentiate dead cells when necessary. Cells were sorted with Aria III (BD) (tagBFP Ex: 405 nm Em: 450/50 nm; Timer510 and SYTOX Green Ex: 488 nm Em: 530/30 nm; Timer580 Ex: 561 nm Em: 586/15 nm; smURFP Ex: 633 nm Em: 660/20 nm) to collect uninfected cells, infected cells with dormant or SPI-2 S. Typhimurium populations. The recorded events were gated according to the strategy described (S2 Fig).

Immunofluorescence microscopy

Cells seeded on coverslips were washed with 1 x PBS (1X) and fixed in 4% PFA (8 min, RT). After washing with 1 x PBS (3X), cells were permeabilized and blocked in 1 x PBS, 20% FBS, 0.25% saponin (30 min, RT). Coverslips were washed with 1 x PBS (3X) and incubated with anti-RAB5, anti-RAB7, anti-RAB11, anti-LC3 or anti-LAMP1 primary antibodies and phalloidin-rhodamine diluted in 1 x PBS, 2% FBS (60 min, RT), and then washed with 1 x PBS (3X) and incubated with Cy5-conjugated goat anti-rabbit secondary antibodies diluted in 1 x PBS, 2% FBS (60 min, RT). Stained coverslips were then washed with 1 x PBS (3X) and mounted on SuperFrost Plus microscope sides (Thermo Scientific) with ProLong Gold Antifade Mountant without DAPI (Invitrogen). Samples were imaged with Perkin Elmer Ultraview confocal spinning disk microscope equipped with Volocity software and a 20X/1.3 NA air objective. Images were analyzed with FIJI (NIH) [52] and figures were prepared using Inkscape (v1.0.1).

Colony forming unit plating

Infected HeLa cells were enriched by cell sorting, where 1000 infected cells were sorted for each sample. The cells were then collected by centrifugation at 500 x g for 5 min, and subsequently lysed in 0.1% Triton X-100 for 5 min at room temperature. The lysed cells were then serially diluted and plated on LB agar plates with appropriate antibiotics.

Dormant S. Typhimurium persistence assay

Infected HeLa cells harboring dormant S. Typhimurium were enriched by cell sorting using the gate Vac-Cyt-, and plated on 12-wells plates in DMEM + 10% FBS + Gen10. The medium was replaced with fresh DMEM + 10% FBS + Gen10 to avoid the growth of S. Typhimurium being released from dead cells. Cells were harvested at 24 h and 168 h pi for analysis and CFU plating.

Ciprofloxacin survival assay

A final concentration of 10 μg/mL of ciprofloxacin (CIP) were supplemented to the cell culture medium of the infected cells at 3 h pi. The cells were harvested at 6 h pi for cell sorting and CFU plating. CIP was administered at 3 h pi, which offered sufficient time for the infected population to differentiate into Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ for downstream enrichment of Vac-Cyt-, Vac+Cyt- populations.

Serial sectioning transmission electron microscopy

At 6 h pi, infected HeLa cells harboring Vac-Cyt- S. Typhimurium were harvested by cell sorting. Enriched cells were allowed to adhere on specific dishes (MatTek) pre-coated with 50 mg/ml fibronectin (Sigma) for 3 hours. For EM sample preparation, the adhered cells were fixed with 4% PFA (EMS), 2.5% glutaraldehyde (Sigma-Aldrich) in 0.2 M HEPES for 1 hour at room temperature. Fixed samples were washed with 1 x PBS for three times, and position of interest were defined by fluorescent light microscopy. For further sample preparation, the fixed cells washed three times by the addition of fresh 0.1 M Caco buffer (pH 7.2) and post-fixed in 1% osmium (EMS) in 0.1 M Caco buffer (pH 7.2) enriched with 1.5% potassium ferrocyanide (Sigma-Aldrich) for 1 h. After three washes in 0.1M Caco buffer, samples were incubated in 0.2% of Tannic acid in water for 30 min at room temperature. Samples are post-fixed for a second time in 1% of osmium for 1 h, washed with water and incubated in 2% uranyl acetate dissolved in 25% ethanol for 1 h. Samples were then gradually dehydrated in an ethanol (Sigma-Aldrich) series ranging from 50% to 100%. Samples were embedded in PolyBed812 resin (EMS), followed by polymerization for 48 h at 60°C. The resin embedded samples were removed from the dishes after gentle heating.

For the correlative microscopy, the region of interest was determined thanks to landmarks printed below embedded samples. Embedded cells were sectioned with an ultramicrotome (Leica, UC7) with 70 nm thickness. Thin serial sections were collected on a single slot grid (Agar scientific). Serial sections were observed with a transmission electron microscope TEM Technai T12 (ThermoFisher) at 120kV.

Statistical analysis

Unless further specified in the figure legend, data were analyzed for statistical significance with a Mann-Whitney test using Prism 8.0 (GraphPad). P value of ≤ 0.05 is considered statistically significant. *P < 0.05, **P < 0.01, *** P < 0.001, **** P < 0.0001, ns: not significant/ P ≥ 0.05.

Supporting information

S1 Table. S. Typhimurium strains used in this study.

(DOCX)

S2 Table. Plasmids used in this study.

(DOCX)

S3 Table. Primers used for molecular cloning in this study.

(DOCX)

S4 Table. Antibodies used in this study.

(DOCX)

S1 Fig. Construction strategy of SINA1.1.

The vacuolar and cytosolic modules were first individually tested with GFP (pM973 and puhpT-GFP), and then switched to tagBFP and smURFP, respectively. The vacuolar (PssaG-tagBFP) and cytosolic (PuhpT-smURFP) modules were subsequently amplified and introduced into pBR322 Timerbac between SphI and SalI sites to yield SINA1.1.

(TIF)

S2 Fig. Gating strategy of SINA1.1 reporter system.

Analyzed events were first gated for “Cells” on SSC-A vs FSC-A plot to remove cell debris. In the “Cells” events, “Uninfected” population was gated by double-negative; “Infected” was gated by double-positive on Timer580 vs Timer510 plot. To gate for the basal intensity of SINA1.1 at 1 h pi, four quadrants were drawn in the “Infected” events on tagBFP::SPI-2 vs smURFP::cytosolic plot, where the biological interpretations of the four quadrants were denoted in the bottom-right sketch.

(TIF)

S3 Fig. Localization modules indicate subcellular localization of S. Typhimurium.

(A) Gating strategy for applying SINA1.7 for digitonin assay. HeLa cells were infected with SINA1.7-harboring wild type S. Typhimurium, and harvested at 6 h pi for analysis by flow cytometry. The events were first gated for “Cells” to remove cell debris and subsequently gated for “uninfected” and “infected” based on DsRed signal. The “infected” events were subsequently gated for Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ on tagBFP::SPI-2 vs smURFP::cytosolic plot. The fluorescence profiles FITC::S. Typhimurium (after immunostaining using anti-S. Typhimurium antibody) of Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ and “uninfected” were plotted as overlay histograms. The gating strategy displays a positive control sample treated with saponin. (B) Schematic diagram for the constructions of the SINA derivative SINA1.7, where Timerbac was replaced with DsRed as compared to SINA1.1. (C) Digitonin assay on SINA-1.7 harboring wild type S. Typhimurium-infected HeLa cells at 6 h pi, signal intensities of uninfected (black), Vac-Cyt- (red), Vac+Cyt- (blue) and Vac+Cyt+ (green) populations immunostained against anti-S. Typhimurium. (D) Digitonin assay on SINA-1.7 harboring wild type S. Typhimurium infected HeLa cells at 6 h pi, signal intensity of Vac-Cyt- population unpermeabilized (black, negative control), permeabilized with digitonin (red) and saponin (maroon, positive control). (E) Digitonin assay on SINA-1.7 harboring wild type S. Typhimurium infected HeLa cells at 6 h pi, signal intensity of Vac+Cyt- population unpermeabilized (black, negative control), permeabilized with digitonin (blue) and saponin (navy, positive control). (F) Digitonin assay on SINA-1.7 harboring wild type S. Typhimurium infected HeLa cells at 6 h pi, signal intensity of Vac+Cyt+ population unpermeabilized (black, negative control), permeabilized with digitonin (green) and saponin (dark Green, positive control).

(TIF)

S4 Fig. SINA1.1 performance in HeLa cells at 2 h, 4 h and 6 h pi.

HeLa cells were infected with wild type S. Typhimurium harboring SINA1.1. (A) Infected cells were harvested and analyzed at time intervals of 2 h, 4 h and 6 h pi. (Left) Timerbac profile of total cells at 2 h (top), 4 h (middle) and 6 h (bottom) pi in HeLa cells. (Right) Fluorescence output of the localization module of infected cells at 2 h (top), 4 h (middle) and 6 h (bottom) pi in HeLa cells. (B-C) Time-lapse microscopic acquisition of the S. Typhimurium intracellular lifestyle. Representative images of SINA1.1 signal output of vacuolar (B) and cytosolic (C) S. Typhimurium. Scare bars are 10 μm.

(TIF)

S5 Fig. S. Typhimurium exhibits distinct replication rates and metabolism in HeLa cells.

HeLa cells were infected with SINA1.1-harboring S. Typhimurium and harvested at 6 h pi for analysis by flow cytometry. The three infected cell populations, Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ on tagBFP::SPI-2 vs smURFP::cytosolic plot were backgated on Timer580 vs Timer510 plot. Timer580 and Timer510 intensities were extracted from each event. (A) Quantification of Green:red ratio of Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ population in Timerbac plot at 6 h pi. Green:red ratios were calculated by dividing Timer510 by Timer580 values, and plotted against infected cell populations. (B) Quantification of the slope of the best-fitted line of Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ population in Timerbac plot at 6 h pi. For each population, a best-fitted line was plotted on the Timer580 vs Timer510 plot to extract the slopes for each infected cell populations. At least a total of 1000 events of infected cells were analyzed by flow cytometry in triplicate experiments. The bars represent the mean value, unpaired t-tests were carried out, *P < 0.05, ****P < 0.0001, ns: not significant.

(TIF)

S6 Fig. Dormant S. Typhimurium are observed as early as 2 h pi in HeLa cells.

HeLa cells were infected with SINA1.1-harboring S. Typhimurium, and harvested at 1 h, 2 h and 3 h pi for analysis by flow cytometry. The infected cells were gated and the fluorescence profiles of vacuolar submodule PssaG-tagBFP at 1 h (black), 2 h (red) and 3 h (blue) pi were plotted as overlaying histograms.

(TIF)

S7 Fig. Performance of SINA1.1 in Caco-2 cells.

Polarized Caco-2 monolayers were infected with SINA1.1-harboring S. Typhimurium and harvested at 1 h and 6 h pi for analysis by flow cytometry. (Left) Timerbac profile of Vac-Cyt- (red) and Vac+Cyt- (blue) populations and total cells (black) at 1 h (top) and 6 h (bottom) pi in Caco-2 cells. (Right) Distribution of Vac-Cyt- and Vac+Cyt- populations at 1 h (top) and 6 h (bottom) pi in polarized Caco-2 cells.

(TIF)

S8 Fig. Performance of SINA1.1 in 3T3 cells.

3T3 cells were infected with SINA1.1-harboring S. Typhimurium and harvested at 1 h, 6 h and 24 h pi for analysis by flow cytometry. (Left) Timerbac profile of Vac-Cyt- (red), Vac+Cyt- (blue) and Vac+Cyt+ (green) populations and total cells (black) at 1 h (top), 6 h (middle) and 24 h (bottom) pi in 3T3 cells. (Right) Distribution of Vac-Cyt-, Vac+Cyt+ and Vac+Cyt+ populations at 1 h (top), 6h (middle) and 24 h (bottom) pi in 3T3 cells.

(TIF)

S9 Fig. Performance of SINA1.1 in THP-1 cells.

Differentiated THP-1 cells were infected with SINA1.1-harboring S. Typhimurium and harvested at 1 h, 6 h and 24 h pi for analysis by flow cytometry. (Left) Timerbac profile of Vac-Cyt- (red) and Vac+Cyt- (blue) populations and total cells (black) at 1 h (top), 6 h (middle) and 24 h (bottom) pi in THP-1 cells. (Right) Distribution of Vac-Cyt- and Vac+Cyt- populations at 1 h (top), 6 h (middle) and 24 h (bottom) pi in differentiated THP-1 cells.

(TIF)

S10 Fig. Serial sectioning TEM determines the subcellular localization of Vac-Cyt- S. Typhimurium.

(A) Brightfield and fluorescent microscopy image of region of interest on MatTek dish. (B) Brightfield and fluorescent microscopy image of cells of interest harboring Vac-Cyt- S. Typhimurium. (C) TEM image of cell of interest in labelled region from (B). (D) Magnified TEM image of labelled region from (C).

(TIF)

S11 Fig. Infected cells harboring dormant S. Typhimurium are viable.

HeLa cells were infected with SINA1.7 harboring S. Typhimurium, harvested at 6 h pi and stained with SYTOX Green and analyzed by flow cytometry. The infected cells were gated and the fluorescence profiles of SYTOX Green in uninfected cell (black), Vac-Cyt- (red), Vac+Cyt- (blue) and Vac+Cyt+ (green) were plotted as offset histograms.

(TIF)

S12 Fig. Ectopic expression of hilA rescues the loss of invasiveness.

HeLa cells were infected with various S. Typhimurium strains and harvested at 6 h pi for flow cytometry analysis. The losses of invasiveness in ΔdksA and ΔrelAspoT mutants are rescued by ectopic expression of hilA from the arabinose inducible cassette in SINA1.9. At least a total of 1000 events of infected cells were analyzed by flow cytometry in triplicate experiments. The bars represent the mean value, unpaired t-test was carried out, ****P < 0.0001.

(TIF)

S1 Movie. Connected to Fig 1D: Time-lapse microscopy shows the fluorescence signal output from SINA1.1 in Vac+Cyt- intracellular S. Typhimurium population.

Brightfield and fluorescence output of Timerbac, PssaG and PuhpT from SINA1.1-harboring S. Typhimurium exhibiting Vac+Cyt- profile. Images were taken every 15 min starting from 1 h pi. (AVI).

(AVI)

S2 Movie. Connected to Fig 1D: Time-lapse microscopy shows the fluorescence signal output from SINA1.1 in Vac+Cyt- and Vac-Cyt+ intracellular S. Typhimurium population.

Brightfield and fluorescence output of Timerbac, PssaG and PuhpT from SINA1.1-harboring S. Typhimurium exhibiting Vac+Cyt- and Vac-Cyt+ profiles. Images were taken every 15 min starting from 1 h pi. (AVI).

(AVI)

S3 Movie. Connected to Fig 1D: Time-lapse microscopy shows the fluorescence signal output from SINA1.1 in Vac-Cyt- intracellular S. Typhimurium population.

Brightfield and fluorescence output of Timerbac, PssaG and PuhpT from SINA1.1-harboring S. Typhimurium exhibiting Vac-Cyt- profile. Images were taken every 15 min starting from 1 h pi. (AVI).

(AVI)

Acknowledgments

We thank the members of the Dynamics of Host-Pathogen Interactions Unit for the constructive comment and discussion. We are grateful for the generous plasmid gift from D. Bumann, and we acknowledge S. Méresse for the P22 lysates of tagged PipB2-2HA.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This research was supported by fellowships from Croucher Foundation (HK) and Fondation pour la Recherche Médicale (FRM) to C.H.L. and Y.Y.C.. C.H.L. is part of the Pasteur - Paris University (PPU) International PhD Program. J.E. is supported by the ERC-CoG “Endosubvert”. The Enninga lab is part of the LabEx IBEID and Milieu Interieure. AM and PB are supported for equipment from the French Government Programme Investissements d’Avenir France BioImaging (FBI, N° ANR-10-INSB-04-01) and are also members of the LabEx IBEID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Stanaway JD, Parisi A, Sarkar K, Blacker BF, Reiner RC, Hay SI, et al. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2019;19: 1312–1324. 10.1016/S1473-3099(19)30418-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Shekhar C. International Conference on Food Security and Sustainable Agriculture Global impact of salmonellosis on health and economy. ~ 93 ~ J Pharmacogn Phytochem. 2018;4. [Google Scholar]
  • 3.Ilyas B, Tsai CN, Coombes BK. Evolution of Salmonella-host cell interactions through a dynamic bacterial genome. Frontiers in Cellular and Infection Microbiology. Frontiers Media S.A.; 2017. p. 428. 10.3389/fcimb.2017.00428 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dandekar T, Astrid F, Jasmin P, Hensel M. Salmonella enterica: a surprisingly well-adapted intracellular lifestyle. Front Microbiol. 2012;3: 164. 10.3389/fmicb.2012.00164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lou L, Zhang P, Piao R, Wang Y. Salmonella Pathogenicity Island 1 (SPI-1) and Its Complex Regulatory Network. Frontiers in Cellular and Infection Microbiology. Frontiers Media S.A.; 2019. p. 270. 10.3389/fcimb.2019.00270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Jennings E, Thurston TLM, Holden DW. Salmonella SPI-2 Type III Secretion System Effectors: Molecular Mechanisms And Physiological Consequences. Cell Host Microbe. 2017;22: 217–231. 10.1016/j.chom.2017.07.009 [DOI] [PubMed] [Google Scholar]
  • 7.LaRock DL, Chaudhary A, Miller SI. Salmonellae interactions with host processes. Nat Rev Microbiol. 2015;13: 191–205. 10.1038/nrmicro3420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Fredlund J, Santos JC, Stévenin V, Weiner A, Latour-Lambert P, Rechav K, et al. The entry of Salmonella in a distinct tight compartment revealed at high temporal and ultrastructural resolution. Cell Microbiol. 2018;20: e12816. 10.1111/cmi.12816 [DOI] [PubMed] [Google Scholar]
  • 9.Stévenin V, Chang YY, Le Toquin Y, Duchateau M, Gianetto QG, Luk CH, et al. Dynamic Growth and Shrinkage of the Salmonella-Containing Vacuole Determines the Intracellular Pathogen Niche. Cell Rep. 2019;29: 3958–3973.e7. 10.1016/j.celrep.2019.11.049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Knodler LA. Salmonella enterica: Living a double life in epithelial cells. Curr Opin Microbiol. 2015;23: 23–31. 10.1016/j.mib.2014.10.010 [DOI] [PubMed] [Google Scholar]
  • 11.López-Montero N, Ramos-Marquès E, Risco C, García-del Portillo F. Intracellular Salmonella induces aggrephagy of host endomembranes in persistent infections. Autophagy. 2016;12: 1886–1901. 10.1080/15548627.2016.1208888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Cano DA, Pucciarelli MG, Martínez-Moya M, Casadesús J, García-Del Portillo F. Selection of small-colony variants of Salmonella enterica serovar Typhimurium in nonphagocytic eucaryotic cells. Infect Immun. 2003;71: 3690–3698. 10.1128/iai.71.7.3690-3698.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Helaine S, Thompson J a., Watson KG, Liu M, Boyle C, Holden DW. Dynamics of Intracellular Bacterial Replication at the Single Cell Level. Proc Natl Acad Sci. 2010;107: 3746–3751. 10.1073/pnas.1000041107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Helaine S, Cheverton AM, Watson KG, Faure LM, Matthews SA, Holden DW. Internalization of salmonella by macrophages induces formation of nonreplicating persisters. Science (80-). 2014;343: 204–208. 10.1126/science.1244705 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lewis K. Persister Cells. Annu Rev Microbiol. 2010;64: 357–372. 10.1146/annurev.micro.112408.134306 [DOI] [PubMed] [Google Scholar]
  • 16.Cheverton AM, Gollan B, Przydacz M, Wong CT, Mylona A, Hare SA, et al. A Salmonella Toxin Promotes Persister Formation through Acetylation of tRNA. Mol Cell. 2016;63: 86–96. 10.1016/j.molcel.2016.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bakkeren E, Huisman JS, Fattinger SA, Hausmann A, Furter M, Egli A, et al. Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut. Nature. 2019; 1–5. 10.1038/s41586-019-1521-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Spinnenhirn V, Farhan H, Basler M, Aichem A, Canaan A, Groettrup M. The ubiquitin-like modifier FAT10 decorates autophagy-targeted Salmonella and contributes to Salmonella resistance in mice. J Cell Sci. 2014;127: 4883–93. 10.1242/jcs.152371 [DOI] [PubMed] [Google Scholar]
  • 19.Hapfelmeier S, Stecher B, Barthel M, Kremer M, Müller AJ, Heikenwalder M, et al. The Salmonella Pathogenicity Island (SPI)-2 and SPI-1 Type III Secretion Systems Allow Salmonella Serovar typhimurium to Trigger Colitis via MyD88-Dependent and MyD88-Independent Mechanisms. J Immunol. 2005;174: 1675–1685. 10.4049/jimmunol.174.3.1675 [DOI] [PubMed] [Google Scholar]
  • 20.Claudi B, Spröte P, Chirkova A, Personnic N, Zankl J, Schürmann N, et al. Phenotypic variation of salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell. 2014;158: 722–733. 10.1016/j.cell.2014.06.045 [DOI] [PubMed] [Google Scholar]
  • 21.Knodler LA, Nair V, Steele-Mortimer O. Quantitative assessment of cytosolic Salmonella in epithelial cells. PLoS One. 2014;9: e84681. 10.1371/journal.pone.0084681 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lau N, Haeberle AL, O’Keeffe BJ, Latomanski EA, Celli J, Newton HJ, et al. SopF, a phosphoinositide binding effector, promotes the stability of the nascent Salmonella-containing vacuole. PLoS Pathog. 2019;15: e1007959. 10.1371/journal.ppat.1007959 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Knodler LA, Vallance BA, Celli J, Winfree S, Hansen B, Montero M, et al. Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia. Proc Natl Acad Sci U S A. 2010;107: 17733–17738. 10.1073/pnas.1006098107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yu HB, Croxen MA, Marchiando AM, Ferreira RBR, Cadwell K, Foster LJ, et al. Autophagy Facilitates Salmonella Replication in HeLa Cells. MBio. 2014;5: e00865–14. 10.1128/mBio.00865-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Birmingham CL, Smith AC, Bakowski MA, Yoshimori T, Brumell JH. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem. 2006;281: 11374–11383. 10.1074/jbc.M509157200 [DOI] [PubMed] [Google Scholar]
  • 26.Terskikh a, Fradkov A, Ermakova G, Zaraisky A, Tan P, Kajava a V, et al. “Fluorescent timer”: protein that changes color with time. Science. 2000;290: 1585–1588. 10.1126/science.290.5496.1585 [DOI] [PubMed] [Google Scholar]
  • 27.Cunrath O, Bumann D. Host resistance factor SLC11A1 restricts Salmonella growth through magnesium deprivation. Science (80-). 2019;366: 995–999. 10.1126/science.aax7898 [DOI] [PubMed] [Google Scholar]
  • 28.Steele-Mortimer O. The Salmonella-containing vacuole-Moving with the times. Current Opinion in Microbiology. NIH Public Access; 2008. pp. 38–45. 10.1016/j.mib.2008.01.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Stapels DAC, Hill PWS, Westermann AJ, Fisher RA, Thurston TL, Saliba A-E, et al. Salmonella persisters undermine host immune defenses during antibiotic treatment. Science (80-). 2018;362: 1156–1160. 10.1126/science.aat7148 [DOI] [PubMed] [Google Scholar]
  • 30.Santos JC, Enninga J. At the crossroads: communication of bacteria-containing vacuoles with host organelles. Cell Microbiol. 2016;18: 330–339. 10.1111/cmi.12567 [DOI] [PubMed] [Google Scholar]
  • 31.Shea JE, Hensel M, Gleeson C, Holden DW. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci U S A. 1996;93: 2593–2597. 10.1073/pnas.93.6.2593 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Greenwood DJ, Dos Santos MS, Huang S, Russell MRG, Collinson LM, MacRae JI, et al. Subcellular antibiotic visualization reveals a dynamic drug reservoir in infected macrophages. Science. 2019;364: 1279–1282. 10.1126/science.aat9689 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Diard M, Hardt W-D. Basic Processes in Salmonella-Host Interactions: Within-Host Evolution and the Transmission of the Virulent Genotype. Microbiol Spectr. 2017;5: 1–11. 10.1128/microbiolspec.MTBP-0012-2016 [DOI] [PubMed] [Google Scholar]
  • 34.Hindle Z, Chatfield SN, Phillimore J, Bentley M, Johnson J, Cosgrove CA, et al. Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect Immun. 2002;70: 3457–3467. 10.1128/iai.70.7.3457-3467.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wood TK, Knabel SJ, Kwan BW. Bacterial Persister Cell Formation and Dormancy. Appl Environ Microbiol. 2013;79: 7116–7121. 10.1128/AEM.02636-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Dalebroux ZD, Svensson SL, Gaynor EC, Swanson MS. ppGpp Conjures Bacterial Virulence. Microbiol Mol Biol Rev. 2010;74: 171–199. 10.1128/MMBR.00046-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Dalebroux ZD, Swanson MS. PpGpp: Magic beyond RNA polymerase. Nature Reviews Microbiology. 2012. pp. 203–212. 10.1038/nrmicro2720 [DOI] [PubMed] [Google Scholar]
  • 38.Helaine S, Kugelberg E. Bacterial persisters: formation, eradication, and experimental systems. Trends Microbiol. 2014;22: 417–424. 10.1016/j.tim.2014.03.008 [DOI] [PubMed] [Google Scholar]
  • 39.Pizarro-Cerdá J, Tedin K. The bacterial signal molecule, ppGpp, regulates Salmonella virulence gene expression. Mol Microbiol. 2004;52: 1827–1844. 10.1111/j.1365-2958.2004.04122.x [DOI] [PubMed] [Google Scholar]
  • 40.Fitzsimmons LF, Liu L, Kant S, Kim J-S, Till JK, Jones-Carson J, et al. SpoT Induces Intracellular Salmonella Virulence Programs in the Phagosome. Swanson MS, editor. MBio. 2020;11. 10.1128/mBio.03397-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Weiner A, Mellouk N, Lopez-Montero N, Chang YY, Souque C, Schmitt C, et al. Macropinosomes are Key Players in Early Shigella Invasion and Vacuolar Escape in Epithelial Cells. PLoS Pathog. 2016;12: 1–24. 10.1371/journal.ppat.1005602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Lobato-Márquez D, Moreno-Córdoba I, Figueroa V, Diáz-Orejas R, Garciá-Del Portillo F. Distinct type i and type II toxin-antitoxin modules control Salmonella lifestyle inside eukaryotic cells. Sci Rep. 2015;5. 10.1038/srep09374 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Hauryliuk V, Atkinson GC, Murakami KS, Tenson T, Gerdes K. Recent functional insights into the role of (p)ppGpp in bacterial physiology. Nature Reviews Microbiology. Na ture Publishing Group; 2015. pp. 298–309. 10.1038/nrmicro3448 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gaca AO, Colomer-Winter C, Lemos JA. Many means to a common end: the intricacies of (p)ppGpp metabolism and its control of bacterial homeostasis. J Bacteriol. 2015;197: 1146–56. 10.1128/JB.02577-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Hobbs JK, Boraston AB. (p)ppGpp and the Stringent Response: An Emerging Threat to Antibiotic Therapy. 2019. [cited 1 Aug 2019]. 10.1021/acsinfecdis.9b00204 [DOI] [PubMed] [Google Scholar]
  • 46.Maisonneuve E, Gerdes K. Molecular Mechanisms Underlying Bacterial Persisters. Cell. 2014;157: 539–548. 10.1016/j.cell.2014.02.050 [DOI] [PubMed] [Google Scholar]
  • 47.Diard M, Bakkeren E, Cornuault JK, Moor K, Hausmann A, Sellin ME, et al. Inflammation boosts bacteriophage transfer between Salmonella spp. Science (80-). 2017;355: 1211–1215. 10.1126/science.aaf8451 [DOI] [PubMed] [Google Scholar]
  • 48.Santiviago CA, Reynolds MM, Porwollik S, Choi S-H, Long F, Andrews-Polymenis HL, et al. Analysis of Pools of Targeted Salmonella Deletion Mutants Identifies Novel Genes Affecting Fitness during Competitive Infection in Mice. Cookson BT, editor. PLoS Pathog. 2009;5: e1000477. 10.1371/journal.ppat.1000477 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Tanenbaum ME, Gilbert LA, Qi LS, Weissman JS, Vale RD. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell. 2014;159: 635–646. 10.1016/j.cell.2014.09.039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Campbell-Valois FX, Schnupf P, Nigro G, Sachse M, Sansonetti PJ, Parsot C. A fluorescent reporter reveals on/off regulation of the shigella type III secretion apparatus during entry and cell-to-cell spread. Cell Host Microbe. 2014;15: 177–189. 10.1016/j.chom.2014.01.005 [DOI] [PubMed] [Google Scholar]
  • 51.Rodriguez EA, Tran GN, Gross LA, Crisp JL, Shu X, Lin JY, et al. A far-red fluorescent protein evolved from a cyanobacterial phycobiliprotein. Nat Methods. 2016;13: 763–769. 10.1038/nmeth.3935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: An open-source platform for biological-image analysis. Nature Methods. Nature Publishing Group; 2012. pp. 676–682. 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Raphael H Valdivia, Jean Celli

28 Dec 2020

Dear Dr Enninga,

Thank you very much for submitting your manuscript "Salmonella  endorses a dormant state within human epithelial cells for persistent infection" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

As you will see from the reviewers' comments, there was some consensual interest and enthusiasm for the development and potential of the SINA tool reported in your manuscript. However, all reviewers raised some significant concerns about the design of some experiments, consideration of the existing literature on Salmonella persisters, and the validity of many important conclusions. All of these concerns need to be carefully addressed in a revised manuscript.  

While many of the reviewers’ comments can be addressed with textual changes, clarifications and revisions of data presentation, addressing several of these concerns requires additional experiments to be performed.  In particular, it appears essential to address the following issues raised by the reviewers in your revised manuscript:

  • All reviewers requested clarifications on the expression of SPI-2 in the newly described dormant population of intracellular Salmonella, via methodologies that would complement and validate the vacuolar reporter part of SINA. This also includes discussing the known roles of SpoT in SPI-2 expression and persisters.

  • Reviewers 1 and 3 requested a deeper characterization of the vacuolar compartment occupied by the dormant Salmonella population, as the data provided in the manuscript was deemed superficial. 

  • Reviewer 2 requested changes in the experiments testing reactivation of dormant bacteria using Ciprofloxacin and addressing the caveat of HilA overexpression on the intracellular behavior of dormant bacteria in the context of SpoT/RelA functions.

  • Reviewer 2’s request to include an experimental comparison of your findings in the fibroblast model of Salmonella persisters should be addressed, given the significance of this model. 

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Jean Celli

Guest Editor

PLOS Pathogens

Raphael Valdivia

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: In this manuscript by Luk et al., the authors construct a new tool (SINA) to characterize distinct populations of Salmonella within enterocytes. They use SINA to identify subpopulations of intracellular Salmonella and describe a population of bacteria that are not within the “classical” SCV or within the cytosol, but seem to reside in an uncharacterized vesicular compartment in a dormant state. The dormant bacteria do not express SPI2 at 6 hours post-infection, but appear to express it at later time points. Finally, they propose that the dormant state is regulated by (p)ppGpp-stringent response through SpoT. The authors propose that dormant Salmonella within epithelial cells mediate persistence. This is a potentially interesting study, however, additional data and controls are needed. The manuscript would benefit from clearly defining at the beginning what dormancy is and how does this compare to persisters.

Reviewer #2: The study has as major strength the combination of previously used fluorescent reporters in new tool that allows to analyze simultaneosuly location and growth status of intracellular Salmonella. Apart from this technical advance, the study is conceptually weak, lacking much comparative discussion with prior work on Salmonella persisters in other cell models. Presentation of the data has also flaws, with some experiments described superficially and obvious controls missing. For example, the “colony forming unit plating” assay described in pag. 19 relates to the data shown in Fig. 4A, but in none of the two sites the cell line in which it was done, is specified. This assay involves a long-term infection (168 h, 7 days). It is not easy to imagine the experimental set-up when using epithelial cells as HeLa that are permissive for bacterial proliferation. Experimental details must be therefore precisely exposed. In general, there is clear overstatement in the conclusions due to the lack of more convincing data.

Reviewer #3: The authors use Salmonella infection as a model to address important questions about bacterial growth in different compartments of host cells. They also ask where Salmonella persisters colonize host cells, and how this is regulated. They develop a new probe (SINA) that indicates both bacterial localization and also metabolic activity at the same time. They propose that a population of dormant bacteria occupies an uncharacterized compartment and can be re-activated upon favorable growth conditions. The strength of this study is the development of new methods and they test these both in vitro and in vivo. This is an interesting study and the results are promising, but I have some questions about the probe and the interpretation of the data.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: 1) the authors claim that the dormant state mediates persistence, but they don’t really show this. First off, they need to define what they mean by persistence. The data presented in Figure 4 are not very convincing. They only show 6 h, 24 h, and 168 h. What happens at times in between? They see that ~50% of the “dormant” bacteria begin to express SPI2 at about 24 hours. Do these bacteria replicate, burst out and reinfect neighboring epithelial cells to start the cycle again? Showing images of these longer infections and more time points in between 1 and 7 days would help sort this out.

2) Movies and images need to show host cells with either phase of DIC imaging. For example, in movie 3, I see some red and green fluorescence, but I have no idea whether they are inside of host cells or extracellular.

3) I’d like to see better characterization of the “unique” vesicular compartment that they claim dormant Salmonella reside in. Fig.3 only shows 1 time point, 6 h and I don’t know what “minor” recruitment of LAMP1 means. Can this be quantitated over a time course? Also, transmission electron microscopy would be nice confirmation that these bacteria are really in a vesicle of some sort.

Reviewer #2: This study combines fluorescent reporters previously used to monitor subcellular localization of Salmonella (vacuolar, cytosolic) with a reporter that provides measure of replication rate based on a “Timer” dsRed variant.

The study does not have a clear starting hypothesis, but the application of this new dual reporter, named SINA, led to the authors to claim the existence of a “third” population of intracellular Salmonella that is intra-vacuolar and would remain in a dormant state form early infection times..

The first part of the study describing the new tools is technically convincing. However, the subsequent sections are much less solid and introduce concepts not supported by the data shown. Moreover, the study is not rigorous with the literature and it lacks many important controls being clearly biased by the data shown in macrophages. This phagocytic cell type is the sole comparator model used, leaving aside and omitting important observations in other models that provided valuable data on Salmonella intracellular persistence.

The study therefore forgets important observations in the Salmonella field regarding the capacity of this pathogen to establish a dormant state inside eukaryotic cells as well as the role of SpoT in controlling the intracellular virulence program. These omissions refer to the work performed in the fibroblast model, including: i) strong SPI-2 activity in non-growing intracellular Salmonella (Nunez-Hernandez et al., Infect Immun 2013, 2014) ; ii) production of several toxin-antitoxin modules by non-growing intracellular S. Typhimurium (Lobato-Marquez et al., Scientific Reports, 2015), none of which was tested here; iii) the selection of genetically table S. Typhimurium mutants with 3-4- logs higher capacity to persist inside the fibroblasts (Cano et al. Infect Immun 2003, 71: 3690-3698); and, iv) the role of SpoT, but not RelA, in producing ppGpp to stimulate activity of SPI-2 in intraphagosomal Salmonella (Fitzsimmons et al., mBio, 2020, 11:e03397-19).

The study also lacks some rational justifications on why to choose exclusively the RelA-SpoT-DskA-Lon axis despite being forced to use “artificial conditions” in which SPI-1 is boosted by in-trans expression of HilA. Invading bacteria with high SPI-1 levels might be transiently prevented to correctly induced the SPI-2 intracellular phase.

These are key experiments that should be addressed:

1) Ciprofloxacin survival assay (p. 19): The experiment involves incubation of infected cells in medium containing the drug. This design does not take into account that the bactericidal action of the drug can modify the physiology of intravacuolar bacteria to render it Vac- from a Vac+ status at the beginning of the treatment. Moreover, the Vac+Cyt+ epithelial cells contain both cytosolic bacteria undergoing rapid growth and intra-vacuolar bacteria with reduced growth rate. This Vac+Cyt+ cell population is included in the Material and Methods’ section (pag. 19) but not shown in Fig. 2D. So, it is uncertain whether or not was tested. Bactericidal effect might be different depending on the growth status inside the host cell. Furthermore, accessibility of the drug to the vacuolar compartments or the cytosol might not be similar. A more convincing experiment is to isolate bacteria from the different populations: Vac-Cyt- and Vac+Cyt- and further exposed to the drug in the test tube for 3 h and then do plating to count CFU next day.

2) Considering the absolute of biochemistry in this study, it is recommended to tag in the chromosome a SPI2-specific gene (e.g. ssrB) and evaluate relative levels in the distinct populations (Vac-Cyt-, Vac+Cyt-, Vac+Cyt+). This must be done after sorting. This approach was useful to demonstrate SPI2 activity in non-growing Salmonella inside fibroblasts (Nunez-Hernandez et al., Infect Immun 2014).

3) It is not obvious why the RelA-SpoT-DskA-Lon axis must be the only that operates to trigger generation of dormant Salmonella in epithelial cells. The work of Lobato-Marquez et al. (Sci Reports, 2015) showed that various TA systems operate in intracellular S. Typhimurium in both epithelial cells and fibroblasts. Unlike the relA, relAspoT and dskA mutants, none of the mutants lacking these TA systems were found to be impaired for invasion. So, no need to artificially manipulate SPI-1. These should be tested.

Reviewer #3: -The new SINA probe is being used to identify a population of dormant bacteria. Are there any other bona fide markers/probes that can be used in tandem to confirm what the authors are concluding? Perhaps RT-PCR or mass spec analysis of cell sorted bacteria would help?

-The new probes are plasmids. Is it stably integrated into the bacterial chromosome? If not, what evidence is there that plasmid loss is not occurring? Again, maybe RT-PCR would help.

-The authors refer to bacteria lacking expression of ssaG (SPI-2 T3SS component, used as marker of vacuolar) and uhpt (hexose 6-phosphate: phosphate antiporter; used as marker of cytosolic bacteria) and having a low metabolic activity as being “dormant”. An alternative interpretation is that these bacteria merely lost the plasmid containing the SINA probe. Or do the bacteria go to a non-acidified compartment without hexose 6-phosphate?

-Supplemental Movie 1. What is the movie supposed to be showing? It might help to have a separate figure with frames from the movie where bacterial signals and populations are highlighted.

-Figure 1D, the labeling is confusing, and not consistent with figure legend. For example, “6h SPI-2” not the same as “vacuolar”. When I first read this I thought a mutant was used, so confused. The addition of colour only to the merged channel makes the situation worse. Importantly, what is the conclusion from this figure? Are vacuolar bacteria less metabolically active than those in the cytosol? Is there a population of fast and slow growing bacteria in the cytosol?

-Figure 1E. Why are there only Vac+Cyt+ bacteria, and not Vac-Cyt+ bacteria? What does this suggest about the probe, or potentially the bacterial entry to the cytosol? The authors should discuss this point.

-pg8 “This revealed that the Vac-Cyt- S.Typhimurium exhibit a similar replication rate (S5A Fig) but a reduced metabolic activity (S5B Fig) compared to Vac+Cyt- S. Typhimurium as depicted by the green:red ratio and slope of Timerbac plot, respectively”. This is a confusing conclusion: how can the authors propose a similar replication rate with reduced metabolic activity? It seems likely the probe is providing an artefactual lack of signal, or the bacteria are in an unusual location such as the cell surface.

-are antibiotics present in the medium during experiments? The authors point out that antibiotics affect dormancy…. Is this driving observed phenotypes? What happens when gentamicin is removed from the medium?

-Movie S3. There does not appear to be any signals. What are we supposed to be looking at?

-pg9, “With SINA1.5, we observed that approximately half of the Vac-

S. Typhimurium did not respond to arabinose induction at designated time intervals

(Fig 2C). Combining this with our observations on the reduced metabolism (S5B Fig),

we were able to put forward the first evidence to propose that the Vac-Cyt- S.

Typhimurium adopts a dormant state (coined as dormant S. Typhimurium hereafter)”. Is arabinose cell permeable? Could a lack of induction simply reflect a disconnection of bacteria in unusual vacuoles from the endocytic pathway?

-pg10 “Therefore, we conclude that dormant S.Typhimurium are localized within a unique membrane-bound compartment distinct from the conventional SCV”. How can the authors conclude the bacteria are present in a cellular compartment if no markers are present? The authors should consider using correlative electron microscopy to visualize what they are calling a dormant population within cells. Staining for ubiquitinated proteins (typically seen on cytosolic bacteria) should also be considered.

-Related to above, what is the morphology of the dormant bacteria? Upon entry to the cytosol some Salmonella increase in size and decrease in antibody staining… does this type of visual analysis suggest dormant bacteria are in the cytosol?

-Are dormant Salmonella found in cells that have Salmonella-induced filaments (Sifs)? Or those that don’t? This would be interesting to know since bacteria that make Sifs are associated with growth of the bacteria.

-Figure 4. Dormant bacteria were isolated by flow sorting… can the authors perform microscopy to show what was purified? Importantly, did the collected bacteria bear the selectable marker of the SINA probe?

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: 1) many sentences don’t make sense. I will give one example of many, e.g. on page 14, first paragraph “This discrepancy lies in the commence of dormancy, capacity to replicate and permeability to the surrounding microenvironment.” I believe that this manuscript would benefit from editing for grammar, word choice and sentence structure.

2) I’m not fond of the use of “endorses” in the title.

3) How does SpoT regulate dormancy? Does it repress SPI2 expression?

4) The figure legends should include all details of statistical analyses and numbers of cells and repetitions for each panel.

Reviewer #2: - Abstract (lines 14-16): In no part of the study the authors show that the dormant bacteria Vac-Cyt- express SPI-2 al later infection times. The next sentence assumes that dormant bacteria could have “lost” SPI2 activity, which is also not demonstrated by any experiment.

- Pag.3 Importance of the work: Line 4 (We found….). This reviewer does not agree with this statement. It assumes, but it does not prove, that formation of dormant bacteria in epithelial is the one that operates in macrophages. Moreover, TacT is vaguely cited, not functionally tested and no phenotypic test is done with any other TA systems reported to be induced by dormant S. Typhimurium.

- Fig. 1C. The colours expected with the two reporters are shown in two cells but the respective names of the reporters are missing.

- Figure 4A. Discussing these data the authors do not cite the work published in 2003 showing cultivability of dormant S. Typhimrium recovered from fibroblasts after one-week infection (Cano et al. Infect Immun.)

- Although the authors insist that regulation of persisters’ formation might differ among distinct cell types, no comparative analysis is shown. This is extremely relevant considering that the studies in fibroblasts as well as those of Helaine’s group in macrophages have linked SPI2 activity to dormant intracellular Salmonella. The only exception is Fig. S8 with THP1 macrophages, in which up to 70% of the Vac-Cyt- population is shown. Where are then the dormant bacteria reported by Helaine’s group present in these macrophages?

- Supplementary figure S4 clearly shows that the Vac-Cyt- population in HeLa decreases over time, chaining from 37.7% at 2 hpi to 7.41% at 6 hpi. The Vac+Cyt- population however remains rather stable, moving from 60% to 76% at 6 hpi. Authors should comment on the significance of this decrease.

- Description or discussion of some data do not reflect accurately the results shown with not alternatives being considered. An example is the “loss” of SPI2 expression in the Vac-Cyt- population, mentioned repeated times. The authors do not discuss about the possibility of these bacteria not triggering SPI2 expression at any time of the infection and remaining frozen at some early stage of SCV biogenesis.

- Another missing discussion is that related to the possibility of Vac-Cyt- intracellular bacteria being masked by other populations the same infected cell. Heterogeneity regarding epithelial cells harbouring Vac+ and Cyt+ bacteria was first characterized by Knodler’s lab and it is also evident in this study. So, Vac-Cyt- bacteria can be also present in some of the infected populations assigned as Vac+Cyt- and Vac+Cyt+.

- The data shown compare the Vac-Cyt- population in other cell lines such as Caco-2 and THP1 are surprising in the sense that they show a much larger Vac-Cyt- populations (34% and 70% at 6 hpi, respectively for each cell line). This reviewer wonders why these cell lines were not selected better than HeLa for the purpose of demonstrating the existence of such dormant bacteria. An additional cell type missing are fibroblasts, in which dormant population predominates versus proliferating bacteria. The SINA tool could be of impressible utility in these alternative models.

- Genetic background (genotype) of the S. Typhimurium wild-type strain in which plasmid were inserted should be indicated in the Table of strains, no just in the text.

- Lines 3 and 5, 3rd paragraph, page 4. Include references.

- Line 12, 3rd paragraph, page 4. Provide more details about the specific metabolic activity.

- Line 2, 1st paragraph, page. Reference of Lobato-Marquez et al. (Sci Rep, 2015) is missing when referring to TA systems.

- The manuscript was not line numbered. To be corrected in future versions.

- The distinct panels of the videos (S1-to-S3) are not labelled for the respective channel shown. Moreover, the lower panel is pixelated in grey scale with no clear image(s) seen.

- Reference 13 is incomplete. It has no journal information.

- 2nd paragraph, page 5: TacT is not introduced first time it is cited.

- Pages 7-9. Figure S3 is cited after S4 and S5.

- Fig 2C: use better contrasting colours for the bars shown in middle panel.

- Fig 2D: What are it the lines connecting the percentage of Dormant and Vac+Vac- populations? Are they independent biological replicas? The legend refers to n = 3.

- Figure 3B: it lacks staining of representative bacteria from Vac+Cyt- and Vac-Cyt+ populations. Labelling of early-medium markers (Rab5, Rab7) is also recommended to dissect the exact nature of compartment in which these dormant are.

- What is Fig. 4B? Please provide a scheme of the experimental design. The way it is described in the legend is not clear at all.

- Line 1, 4th paragraph, page 11. First sentence seems incorrect. Please, rephrase.

- Page 13. Discussion refers to “first” S. Typhimurium persisters reporter in macrophages. Chronologically, the last paragraph is not correct. See comments above about earlier studies in fibroblasts.

- Discussion is unnecessary long. It should be shortened by at least one page.

Reviewer #3: -Title: I’m not sure “endorses” is the right word to use…

-Short title: perhaps “in enterocytes” is better?

-Supplemental movies: it would help to label the frames so we know what we are looking at.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plospathogens/s/submission-guidelines#loc-materials-and-methods

Decision Letter 1

Raphael H Valdivia, Jean Celli

8 Apr 2021

Dear Dr Enninga,

We are pleased to inform you that your manuscript 'Salmonella  enters a dormant state within human epithelial cells for persistent infection' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Jean Celli

Guest Editor

PLOS Pathogens

Raphael Valdivia

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Dear Jost,

The revised version of your manuscript was sent back to the reviewers, who were satisfied with your responses to their original comments. I concur with their recommendations and consider that no further revisions are needed. Congratulations on this very interesting study.

Best regards,

Jean

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: The authors have addressed my concerns.

Reviewer #3: (No Response)

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: (No Response)

Reviewer #3: (No Response)

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: (No Response)

Reviewer #3: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

Acceptance letter

Raphael H Valdivia, Jean Celli

28 Apr 2021

Dear Dr. Enninga,

We are delighted to inform you that your manuscript, "Salmonella enters a dormant state within human epithelial cells for persistent infection ," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. S. Typhimurium strains used in this study.

    (DOCX)

    S2 Table. Plasmids used in this study.

    (DOCX)

    S3 Table. Primers used for molecular cloning in this study.

    (DOCX)

    S4 Table. Antibodies used in this study.

    (DOCX)

    S1 Fig. Construction strategy of SINA1.1.

    The vacuolar and cytosolic modules were first individually tested with GFP (pM973 and puhpT-GFP), and then switched to tagBFP and smURFP, respectively. The vacuolar (PssaG-tagBFP) and cytosolic (PuhpT-smURFP) modules were subsequently amplified and introduced into pBR322 Timerbac between SphI and SalI sites to yield SINA1.1.

    (TIF)

    S2 Fig. Gating strategy of SINA1.1 reporter system.

    Analyzed events were first gated for “Cells” on SSC-A vs FSC-A plot to remove cell debris. In the “Cells” events, “Uninfected” population was gated by double-negative; “Infected” was gated by double-positive on Timer580 vs Timer510 plot. To gate for the basal intensity of SINA1.1 at 1 h pi, four quadrants were drawn in the “Infected” events on tagBFP::SPI-2 vs smURFP::cytosolic plot, where the biological interpretations of the four quadrants were denoted in the bottom-right sketch.

    (TIF)

    S3 Fig. Localization modules indicate subcellular localization of S. Typhimurium.

    (A) Gating strategy for applying SINA1.7 for digitonin assay. HeLa cells were infected with SINA1.7-harboring wild type S. Typhimurium, and harvested at 6 h pi for analysis by flow cytometry. The events were first gated for “Cells” to remove cell debris and subsequently gated for “uninfected” and “infected” based on DsRed signal. The “infected” events were subsequently gated for Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ on tagBFP::SPI-2 vs smURFP::cytosolic plot. The fluorescence profiles FITC::S. Typhimurium (after immunostaining using anti-S. Typhimurium antibody) of Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ and “uninfected” were plotted as overlay histograms. The gating strategy displays a positive control sample treated with saponin. (B) Schematic diagram for the constructions of the SINA derivative SINA1.7, where Timerbac was replaced with DsRed as compared to SINA1.1. (C) Digitonin assay on SINA-1.7 harboring wild type S. Typhimurium-infected HeLa cells at 6 h pi, signal intensities of uninfected (black), Vac-Cyt- (red), Vac+Cyt- (blue) and Vac+Cyt+ (green) populations immunostained against anti-S. Typhimurium. (D) Digitonin assay on SINA-1.7 harboring wild type S. Typhimurium infected HeLa cells at 6 h pi, signal intensity of Vac-Cyt- population unpermeabilized (black, negative control), permeabilized with digitonin (red) and saponin (maroon, positive control). (E) Digitonin assay on SINA-1.7 harboring wild type S. Typhimurium infected HeLa cells at 6 h pi, signal intensity of Vac+Cyt- population unpermeabilized (black, negative control), permeabilized with digitonin (blue) and saponin (navy, positive control). (F) Digitonin assay on SINA-1.7 harboring wild type S. Typhimurium infected HeLa cells at 6 h pi, signal intensity of Vac+Cyt+ population unpermeabilized (black, negative control), permeabilized with digitonin (green) and saponin (dark Green, positive control).

    (TIF)

    S4 Fig. SINA1.1 performance in HeLa cells at 2 h, 4 h and 6 h pi.

    HeLa cells were infected with wild type S. Typhimurium harboring SINA1.1. (A) Infected cells were harvested and analyzed at time intervals of 2 h, 4 h and 6 h pi. (Left) Timerbac profile of total cells at 2 h (top), 4 h (middle) and 6 h (bottom) pi in HeLa cells. (Right) Fluorescence output of the localization module of infected cells at 2 h (top), 4 h (middle) and 6 h (bottom) pi in HeLa cells. (B-C) Time-lapse microscopic acquisition of the S. Typhimurium intracellular lifestyle. Representative images of SINA1.1 signal output of vacuolar (B) and cytosolic (C) S. Typhimurium. Scare bars are 10 μm.

    (TIF)

    S5 Fig. S. Typhimurium exhibits distinct replication rates and metabolism in HeLa cells.

    HeLa cells were infected with SINA1.1-harboring S. Typhimurium and harvested at 6 h pi for analysis by flow cytometry. The three infected cell populations, Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ on tagBFP::SPI-2 vs smURFP::cytosolic plot were backgated on Timer580 vs Timer510 plot. Timer580 and Timer510 intensities were extracted from each event. (A) Quantification of Green:red ratio of Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ population in Timerbac plot at 6 h pi. Green:red ratios were calculated by dividing Timer510 by Timer580 values, and plotted against infected cell populations. (B) Quantification of the slope of the best-fitted line of Vac-Cyt-, Vac+Cyt- and Vac+Cyt+ population in Timerbac plot at 6 h pi. For each population, a best-fitted line was plotted on the Timer580 vs Timer510 plot to extract the slopes for each infected cell populations. At least a total of 1000 events of infected cells were analyzed by flow cytometry in triplicate experiments. The bars represent the mean value, unpaired t-tests were carried out, *P < 0.05, ****P < 0.0001, ns: not significant.

    (TIF)

    S6 Fig. Dormant S. Typhimurium are observed as early as 2 h pi in HeLa cells.

    HeLa cells were infected with SINA1.1-harboring S. Typhimurium, and harvested at 1 h, 2 h and 3 h pi for analysis by flow cytometry. The infected cells were gated and the fluorescence profiles of vacuolar submodule PssaG-tagBFP at 1 h (black), 2 h (red) and 3 h (blue) pi were plotted as overlaying histograms.

    (TIF)

    S7 Fig. Performance of SINA1.1 in Caco-2 cells.

    Polarized Caco-2 monolayers were infected with SINA1.1-harboring S. Typhimurium and harvested at 1 h and 6 h pi for analysis by flow cytometry. (Left) Timerbac profile of Vac-Cyt- (red) and Vac+Cyt- (blue) populations and total cells (black) at 1 h (top) and 6 h (bottom) pi in Caco-2 cells. (Right) Distribution of Vac-Cyt- and Vac+Cyt- populations at 1 h (top) and 6 h (bottom) pi in polarized Caco-2 cells.

    (TIF)

    S8 Fig. Performance of SINA1.1 in 3T3 cells.

    3T3 cells were infected with SINA1.1-harboring S. Typhimurium and harvested at 1 h, 6 h and 24 h pi for analysis by flow cytometry. (Left) Timerbac profile of Vac-Cyt- (red), Vac+Cyt- (blue) and Vac+Cyt+ (green) populations and total cells (black) at 1 h (top), 6 h (middle) and 24 h (bottom) pi in 3T3 cells. (Right) Distribution of Vac-Cyt-, Vac+Cyt+ and Vac+Cyt+ populations at 1 h (top), 6h (middle) and 24 h (bottom) pi in 3T3 cells.

    (TIF)

    S9 Fig. Performance of SINA1.1 in THP-1 cells.

    Differentiated THP-1 cells were infected with SINA1.1-harboring S. Typhimurium and harvested at 1 h, 6 h and 24 h pi for analysis by flow cytometry. (Left) Timerbac profile of Vac-Cyt- (red) and Vac+Cyt- (blue) populations and total cells (black) at 1 h (top), 6 h (middle) and 24 h (bottom) pi in THP-1 cells. (Right) Distribution of Vac-Cyt- and Vac+Cyt- populations at 1 h (top), 6 h (middle) and 24 h (bottom) pi in differentiated THP-1 cells.

    (TIF)

    S10 Fig. Serial sectioning TEM determines the subcellular localization of Vac-Cyt- S. Typhimurium.

    (A) Brightfield and fluorescent microscopy image of region of interest on MatTek dish. (B) Brightfield and fluorescent microscopy image of cells of interest harboring Vac-Cyt- S. Typhimurium. (C) TEM image of cell of interest in labelled region from (B). (D) Magnified TEM image of labelled region from (C).

    (TIF)

    S11 Fig. Infected cells harboring dormant S. Typhimurium are viable.

    HeLa cells were infected with SINA1.7 harboring S. Typhimurium, harvested at 6 h pi and stained with SYTOX Green and analyzed by flow cytometry. The infected cells were gated and the fluorescence profiles of SYTOX Green in uninfected cell (black), Vac-Cyt- (red), Vac+Cyt- (blue) and Vac+Cyt+ (green) were plotted as offset histograms.

    (TIF)

    S12 Fig. Ectopic expression of hilA rescues the loss of invasiveness.

    HeLa cells were infected with various S. Typhimurium strains and harvested at 6 h pi for flow cytometry analysis. The losses of invasiveness in ΔdksA and ΔrelAspoT mutants are rescued by ectopic expression of hilA from the arabinose inducible cassette in SINA1.9. At least a total of 1000 events of infected cells were analyzed by flow cytometry in triplicate experiments. The bars represent the mean value, unpaired t-test was carried out, ****P < 0.0001.

    (TIF)

    S1 Movie. Connected to Fig 1D: Time-lapse microscopy shows the fluorescence signal output from SINA1.1 in Vac+Cyt- intracellular S. Typhimurium population.

    Brightfield and fluorescence output of Timerbac, PssaG and PuhpT from SINA1.1-harboring S. Typhimurium exhibiting Vac+Cyt- profile. Images were taken every 15 min starting from 1 h pi. (AVI).

    (AVI)

    S2 Movie. Connected to Fig 1D: Time-lapse microscopy shows the fluorescence signal output from SINA1.1 in Vac+Cyt- and Vac-Cyt+ intracellular S. Typhimurium population.

    Brightfield and fluorescence output of Timerbac, PssaG and PuhpT from SINA1.1-harboring S. Typhimurium exhibiting Vac+Cyt- and Vac-Cyt+ profiles. Images were taken every 15 min starting from 1 h pi. (AVI).

    (AVI)

    S3 Movie. Connected to Fig 1D: Time-lapse microscopy shows the fluorescence signal output from SINA1.1 in Vac-Cyt- intracellular S. Typhimurium population.

    Brightfield and fluorescence output of Timerbac, PssaG and PuhpT from SINA1.1-harboring S. Typhimurium exhibiting Vac-Cyt- profile. Images were taken every 15 min starting from 1 h pi. (AVI).

    (AVI)

    Attachment

    Submitted filename: LukEtAl_ResponseReviewers_Final_2403_cleaned.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Pathogens are provided here courtesy of PLOS

    RESOURCES